盐酸氟西汀调控神经干细胞信号通路及下游基因表达的实验研究
摘要
目的应用P13K特异性阻滞剂LY294002孵育大鼠神经干细胞,探讨P13K信号转导途径在神经干细胞中的作用。
方法体外分离、培养大鼠NSCs,应用不同浓度的LY294002孵育NSCs后进行WTS-8、BrdU和βTubulin-Ⅲ检测。
结果低浓度的LY294002对NSCs的存活、增殖和分化没有明显影响,在LY294002较高浓度时,NSCs的存活率明显下降(P＜0.05)、BrdU和βTubulin-Ⅲ的阳性细胞数明显少于正常对照组(P＜0.05)。
结论PI3K信号转导途径对大鼠NSCs的存活、增殖、分化起重要作用。
目的应用MAPKK/MEK特异性阻滞剂PD98059孵育大鼠神经干细胞,探讨MAPK信号通路在神经干细胞中的作用。
方法体外分离、培养大鼠NSCs,应用不同浓度的PD98059孵育NSCs后进行WTS-8、BrdU和βTubulin-Ⅲ检测。
结果低浓度的PD98059对NSCs的存活、增殖和分化没有明显影响,在PD98059较高浓度时,NSCs的存活率明显下降(P＜0.05)、BrdU和βTubulin-Ⅲ的阳性细胞数明显少于正常对照组(P＜0.05)。
结论MAPK信号通路对大鼠NSCs的存活、增殖、分化起重要作用。
目的应用PI3K特异性阻滞剂LY294002、MAPKK/MEK特异性阻滞剂PD98059和选择性5-羟色胺再摄取抑制剂(selective serotoninreuptake inhibitors,SSRIs)类抗抑郁药物盐酸氟西汀(Fluoxetine)孵育大鼠神经干细胞,探讨盐酸氟西汀对神经干细胞的PI3K/AKT和MAPK/ERK信号通路的影响。
方法体外分离、培养大鼠NSCs,分别应用LY294002、PD98059和盐酸氟西汀孵育NSCs后进行Western Blotting检测。
结果Western Blotting检测显示盐酸氟西汀能上调磷酸化AKT和磷酸化ERK1/2在蛋白水平的表达。
结论在大鼠神经干细胞模型中,盐酸氟西汀可以上调磷酸化AKT和磷酸化ERK1/2的蛋白表达水平,在盐酸氟西汀激活AKT和ERK1/2的过程中,PI3K/AKT信号通路与MEK/ERK信号通路之间在AKT-ERK1/2水平存在着“对话”(cross-talk)现象。
目的应用PI3K特异性阻滞剂LY294002、MEK特异性阻滞剂PD98059和选择性5-羟色胺再摄取抑制剂(selective serotonin reuptakeinhibitors,SSRIs)类抗抑郁药物盐酸氟西汀(Fluoxetine)孵育大鼠神经干细胞,探讨盐酸氟西汀对神经干细胞下游基因表达的影响。
方法体外分离、培养大鼠NSCs,分别应用LY294002、PD98059和盐酸氟西汀孵育NSCs后进行real-time RT-PCR检测。
结果real-time RT-PCR检测显示盐酸氟西汀能上调BDNF、GDNF、LIF和BCL-2的基因表达,对CNTF和ILGF1/2的基因表达没有影响。
结论在大鼠神经干细胞模型中,盐酸氟西汀可以上调BDNF、GDNF、LIF和BCL-2的基因表达水平,而且是通过PI3K/AKT或(和)MEK/ERK信号转导途径上调上述基因的表达。BDNF、GDNF、LIF和BCL-2是与盐酸氟西汀作用相关的下游信号分子靶点,CNTF和ILGF1/2不是盐酸氟西汀作用的下游信号分子靶点。
Objective To apply selective specific inhibitor(LY294002) of PI3K to incubate the rat neural stem cells to research the effect of PI3K signal transduction pathway in neural stem cells.
Methods To isolate,culture the NSCs derived from E15-16 rats,carry out WTS-8 assay,BrdU andβTubulin-Ⅲimmunofluorescent staining after incubated NSCs in different concentration of LY294002.
Results There was not obvious effect in the survival,proliferation and differentiation of NSCs incubated by low concentration LY294002.The viability of the NSCs decreased significantly than the control(P＜0.05),the amount of BrdU andβTubulin-Ⅲpositive cells were notably fewer than the control(P＜0.05) after they were incubated by the higher concentration LY294002.
Conclusion The PI3K signal transduction pathway played a vital role in the survival,proliferation and differentiation of NSCs.
Objective To apply selective specific inhibitor(PD98059) of MAPKK/MEK to incubate the rat neural stem cells to research the effect of MAPK signal transduction pathway in neural stem cells.
Methods To isolate,culture the NSCs derived from E15-16 rats,carry out WTS-8 assay,BrdU andβTubulin-Ⅲimmunofluorescent staining after incubated NSCs in different concentration of PD98059.
Results There was not obvious effect in the survival,proliferation and differentiation of NSCs incubated by low concentration PD98059.The viability of the NSCs decreased significantly than the control(P＜0.05 ),the amount of BrdU andβTubulin-Ⅲpositive cells were notably fewer than the control(P＜0.05) after they were incubated by the higher concentration PD98059.
Conclusion The MAPK signal transduction pathway played a vital role in the survival,proliferation and differentiation of NSCs.
Objective To apply the phosphatidylinositol-3-kinase(PI3-K) inhibitor(LY294002),the mitogen-activated protein kinase kinase(MEK) inhibitor(PD98059) and antidepressant drugs fluoxetine(the selective serotonin reuptake inhibitors) to incubate the rat neural stem cells to research the effect of the role of PI3K/AKT and MAPK/ERK and signaling pathways in fluoxetine treated neural stem cells.
Methods To isolate,culture the NSCs derived from E15-16 rats and carried out the Western Blotting detection after respectively incubated NSCs with the phosphatidylinositol-3-kinase(PI3-K) inhibitor (LY294002),the mitogen-activated protein kinase kinase(MEK) inhibitor (PD98059) and fluoxetine.
Results The fluoxetine can activated AKT,ERK1/2 protein expression of rats NSCs.
Conclusion The fluoxetine can activated AKT,ERK1/2 protein expression of rats NSCs and there was cross-talk between PI3K/AKT pathway and MAPK/ERK pathway at the level of AKT-ERK1/2 in the process of fluoxetine activated AKT、ERK1/2 protein.
Objective To apply the phosphatidylinositol-3-kinase(PI3-K) inhibitor(LY294002),the mitogen-activated protein kinase kinase(MEK) inhibitor(PD98059) and antidepressant drugs fluoxetine(the selective serotonin reuptake inhibitors) to incubate the rat neural stem cells to research the expression of downstream genes in fluoxetine-treated neural stem cells.
Methods To isolate,culture the NSCs derived from E15-16 rats and carried out the real-time RT-PCR detection after respectively incubated NSCs with the phosphatidylinositol-3-kinase(PI3-K) inhibitor (LY294002),the mitogen-activated protein kinase kinase(MEK) inhibitor (PD98059) and fluoxetine.
Results The fluoxetine can upregulated the mRNA expression of BDNF,GDNF,LIF and BCL-2 in rats NSCs and can not regulated the mRNA expression of CNTF and ILGF1/2.
Conclusion The mRNA expression of BDNF,GDNF,LIF and BCL-2 can be up-regulated by fluoxetine through PI3K and(or) MAPK mediated pathway in NSCs.BDNF,GDNF,LIF and BCL-2 not CNTF and ILGF1/2 were the downstream signaling molecule targets of fluoxetine.
方法体外分离、培养大鼠NSCs,应用不同浓度的LY294002孵育NSCs后进行WTS-8、BrdU和βTubulin-Ⅲ检测。
结果低浓度的LY294002对NSCs的存活、增殖和分化没有明显影响,在LY294002较高浓度时,NSCs的存活率明显下降(P＜0.05)、BrdU和βTubulin-Ⅲ的阳性细胞数明显少于正常对照组(P＜0.05)。
结论PI3K信号转导途径对大鼠NSCs的存活、增殖、分化起重要作用。
目的应用MAPKK/MEK特异性阻滞剂PD98059孵育大鼠神经干细胞,探讨MAPK信号通路在神经干细胞中的作用。
方法体外分离、培养大鼠NSCs,应用不同浓度的PD98059孵育NSCs后进行WTS-8、BrdU和βTubulin-Ⅲ检测。
结果低浓度的PD98059对NSCs的存活、增殖和分化没有明显影响,在PD98059较高浓度时,NSCs的存活率明显下降(P＜0.05)、BrdU和βTubulin-Ⅲ的阳性细胞数明显少于正常对照组(P＜0.05)。
结论MAPK信号通路对大鼠NSCs的存活、增殖、分化起重要作用。
目的应用PI3K特异性阻滞剂LY294002、MAPKK/MEK特异性阻滞剂PD98059和选择性5-羟色胺再摄取抑制剂(selective serotoninreuptake inhibitors,SSRIs)类抗抑郁药物盐酸氟西汀(Fluoxetine)孵育大鼠神经干细胞,探讨盐酸氟西汀对神经干细胞的PI3K/AKT和MAPK/ERK信号通路的影响。
方法体外分离、培养大鼠NSCs,分别应用LY294002、PD98059和盐酸氟西汀孵育NSCs后进行Western Blotting检测。
结果Western Blotting检测显示盐酸氟西汀能上调磷酸化AKT和磷酸化ERK1/2在蛋白水平的表达。
结论在大鼠神经干细胞模型中,盐酸氟西汀可以上调磷酸化AKT和磷酸化ERK1/2的蛋白表达水平,在盐酸氟西汀激活AKT和ERK1/2的过程中,PI3K/AKT信号通路与MEK/ERK信号通路之间在AKT-ERK1/2水平存在着“对话”(cross-talk)现象。
目的应用PI3K特异性阻滞剂LY294002、MEK特异性阻滞剂PD98059和选择性5-羟色胺再摄取抑制剂(selective serotonin reuptakeinhibitors,SSRIs)类抗抑郁药物盐酸氟西汀(Fluoxetine)孵育大鼠神经干细胞,探讨盐酸氟西汀对神经干细胞下游基因表达的影响。
方法体外分离、培养大鼠NSCs,分别应用LY294002、PD98059和盐酸氟西汀孵育NSCs后进行real-time RT-PCR检测。
结果real-time RT-PCR检测显示盐酸氟西汀能上调BDNF、GDNF、LIF和BCL-2的基因表达,对CNTF和ILGF1/2的基因表达没有影响。
结论在大鼠神经干细胞模型中,盐酸氟西汀可以上调BDNF、GDNF、LIF和BCL-2的基因表达水平,而且是通过PI3K/AKT或(和)MEK/ERK信号转导途径上调上述基因的表达。BDNF、GDNF、LIF和BCL-2是与盐酸氟西汀作用相关的下游信号分子靶点,CNTF和ILGF1/2不是盐酸氟西汀作用的下游信号分子靶点。
Objective To apply selective specific inhibitor(LY294002) of PI3K to incubate the rat neural stem cells to research the effect of PI3K signal transduction pathway in neural stem cells.
Methods To isolate,culture the NSCs derived from E15-16 rats,carry out WTS-8 assay,BrdU andβTubulin-Ⅲimmunofluorescent staining after incubated NSCs in different concentration of LY294002.
Results There was not obvious effect in the survival,proliferation and differentiation of NSCs incubated by low concentration LY294002.The viability of the NSCs decreased significantly than the control(P＜0.05),the amount of BrdU andβTubulin-Ⅲpositive cells were notably fewer than the control(P＜0.05) after they were incubated by the higher concentration LY294002.
Conclusion The PI3K signal transduction pathway played a vital role in the survival,proliferation and differentiation of NSCs.
Objective To apply selective specific inhibitor(PD98059) of MAPKK/MEK to incubate the rat neural stem cells to research the effect of MAPK signal transduction pathway in neural stem cells.
Methods To isolate,culture the NSCs derived from E15-16 rats,carry out WTS-8 assay,BrdU andβTubulin-Ⅲimmunofluorescent staining after incubated NSCs in different concentration of PD98059.
Results There was not obvious effect in the survival,proliferation and differentiation of NSCs incubated by low concentration PD98059.The viability of the NSCs decreased significantly than the control(P＜0.05 ),the amount of BrdU andβTubulin-Ⅲpositive cells were notably fewer than the control(P＜0.05) after they were incubated by the higher concentration PD98059.
Conclusion The MAPK signal transduction pathway played a vital role in the survival,proliferation and differentiation of NSCs.
Objective To apply the phosphatidylinositol-3-kinase(PI3-K) inhibitor(LY294002),the mitogen-activated protein kinase kinase(MEK) inhibitor(PD98059) and antidepressant drugs fluoxetine(the selective serotonin reuptake inhibitors) to incubate the rat neural stem cells to research the effect of the role of PI3K/AKT and MAPK/ERK and signaling pathways in fluoxetine treated neural stem cells.
Methods To isolate,culture the NSCs derived from E15-16 rats and carried out the Western Blotting detection after respectively incubated NSCs with the phosphatidylinositol-3-kinase(PI3-K) inhibitor (LY294002),the mitogen-activated protein kinase kinase(MEK) inhibitor (PD98059) and fluoxetine.
Results The fluoxetine can activated AKT,ERK1/2 protein expression of rats NSCs.
Conclusion The fluoxetine can activated AKT,ERK1/2 protein expression of rats NSCs and there was cross-talk between PI3K/AKT pathway and MAPK/ERK pathway at the level of AKT-ERK1/2 in the process of fluoxetine activated AKT、ERK1/2 protein.
Objective To apply the phosphatidylinositol-3-kinase(PI3-K) inhibitor(LY294002),the mitogen-activated protein kinase kinase(MEK) inhibitor(PD98059) and antidepressant drugs fluoxetine(the selective serotonin reuptake inhibitors) to incubate the rat neural stem cells to research the expression of downstream genes in fluoxetine-treated neural stem cells.
Methods To isolate,culture the NSCs derived from E15-16 rats and carried out the real-time RT-PCR detection after respectively incubated NSCs with the phosphatidylinositol-3-kinase(PI3-K) inhibitor (LY294002),the mitogen-activated protein kinase kinase(MEK) inhibitor (PD98059) and fluoxetine.
Results The fluoxetine can upregulated the mRNA expression of BDNF,GDNF,LIF and BCL-2 in rats NSCs and can not regulated the mRNA expression of CNTF and ILGF1/2.
Conclusion The mRNA expression of BDNF,GDNF,LIF and BCL-2 can be up-regulated by fluoxetine through PI3K and(or) MAPK mediated pathway in NSCs.BDNF,GDNF,LIF and BCL-2 not CNTF and ILGF1/2 were the downstream signaling molecule targets of fluoxetine.
引文
[1] Lewis C. Cantley.The Phosphoinositide 3-Kinase Pathway[J].Science, 2002, 296 (5573): 1655-1657
[2] Erin E. Rodgers and Anne B. Theibert. Functions of PI 3-kinase in development of the nervous system[J].International Journal of Development Neuroscience, 2002,20(3-5): 187-197
[3] F.H. Gage. Mammalian neural stem cells[J].Science ,2000,287(5457): 1433-1438.
[4] S. Goldman.Stem and progenitor cell-based therapy of the human central nervous system[J].Nat. Biotechnol. 2005, 23 (7) 862-871.
[5]Downward J.Signal transduction:Regulating S6 kinase.[J].Nature, 1994;371(6496): 378-379.
[6] Sirén AL Ehrenreich H.Erythropoietin a novel concept for neuroprotection[J]. Eur Arch Psychiatry Clin Neurosci,2001,251 (4): 179-184
[7] Timothy G. Cross, Dagmar Scheel-Toellner,et al. Serine/Threonine Protein Kinases and Apoptosis[J]. Experimental Cell Research,2000,256(1):34-41
[1]Schaeffer HJ,Weber MJ.Mitogen-activated protein kinases:specific messages from ubiquitous messengers[J].Mol.Cell.Biol.1999(4) 19:2435-2444
[2]Philippe Lenormand,Jean-Marc Brondello,Anne Brunet,et al.Growth Factor-induced p42/p44 MAPK Nuclear Translocation and Retention Requires Both MAPK Activation and Neosynthesis of Nuclear Anchoring Proteins[J].Cell Biol.1998,142(3):625-633
[3]Huang EJ,Reichardt LF.Neurotrophins:roles in neuronal development and function.[J].Annu Rev Neurosci,2001,24:677-736.
[4]Marinissen MJ,Gutkind JS.G-protein-coupled receptors and signaling networks:emerging paradigms[J].Trends Pharmacol Sci,2001,22(7):368-376.
[5]Dawson TM,Ginty DD.CREB family transcription factors inhibit neuronal suicide [J].Nat Med.2002,8(5):450-451.
[6]Weeber EJ,Sweatt JD.Molecular neurobiology of human cognition[J].Neuron 2002,33(6):845-848.
[7]F.H.Gage.Mammalian neural stem cells[J].Science,2000,287(5457):1433-1438.
[8]S.Goldman.Stem and progenitor cell-based therapy of the human central nervous system[J].Nat.Biotechnol.2005,23(7):862-871.
[1]杨德森.行为医学[M].湖南科学技术出版社.1999,400.
[2]Czeh B,Michaelis T,Watanabe T,et al.Stress-induced changes in cerebral metabolites,hippocampal volume,and cell proliferation are prevented by antidepressant treatment with tianeptine[J].Proc Natl Acad Sci USA,2001,98(22):12796-12801.
[3]Fossati P,Radtchenko A,Boyer P.Neuroplasticity:from MRI to depressive symptoms[J].Eur Neuropsychopharmacol,2004,14Supp 15:S503-510
[4]Sheline Y,Wang P,Gado M,et al.Hippocampal atrophy in recurrent major depression[J].Proc Natl Acad Sci USA,1996,93(9):3908-3913.
[5]Malberg JE,Eisch AJ,Nestler EJ,et al.Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus[J].The Journal of Neuroscience Neurosci 2000,20(24):9104-9110.
[6]Malberg JE,Schechter LE.Increasing hippocampal neurogenesis:a novel mechanism for antidepressant drugs[J].Currrnt Pharmaceutical Design,2005,11(2):145-155
[7]张黎明,李云峰,宫泽辉.神经元再生:抑郁症治疗的新策略[J].生理科学进展2005,36,(2):109-112.
[8] L Santarelli, M Saxe, C Gross,et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants[J].Science, 2003,301 (5634):805-809.
[9] Bunney W E and Davis J M.Norepinephrine in depressive reactions. A review Arch [J].Gern.Psychiatry, 1965,13(6):483-494.
[10] A Cipriani, P Brambilla, T Furukawa,et al. Fluoxetine versus other types of pharmacotherapy for depression[J].Cochrane Database Syst. Rev.2005,19(4)CD004185.
[11] H J Lee, J W Kim, S V Yim, et al.Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats.[J] Mol.Psychiatry 2001,6(6)610,725-728.
[12] Leevers, S. J., Vanhaesebroeck, B., and Waterfield, M. D. Signalling through phosphoinositide 3-kinases: the lipids take centre stage[J]. Curr.Opin. Cell Biol. 1999,11(2), 219-225
[13] Brunet, A, Datta, S R, and Greenberg, M E.Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway[J]. Curr. Opin. Neurobiol. 2001,11(3), 297-305
[14] Hawkins, P T, Anderson, K E, Davidson, K, and Stephens, L R. Signalling through Class I PI3Ks in mammalian cells[J].Biochem. Soc. Trans. 2006,34 (Pt5), 647-662
[15] Hsiung SC, Adlersberg M, Arango V,et al.Attenuated 5-HT1A receptor signaling in brains of suicide victims: Involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase[J]. J Neurochem 2003,87(1): 182-194.
[16] Karege F, Perroud N, Burkhardt S,et al.Alteration in kinase activity but not in protein levels of protein kinaseB and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims[J]. Biol Psychiatry 2007,61(2): 240-245.
[17] Krishnan V, Han M H, Mazei-Robison M, et al.AKT Signaling within the Ventral Tegmental Area Regulates Cellular and Behavioral Responses to Stressful Stimuli [J].Biol Psychiatry. 2008,64(8):691-700.
[18] Einat H, Yuan P, Gould TD,et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation[J].J Neurosci. 2003;23(19): 7311-7316.
[19] Mercier G, Lennon AM, Renouf B, et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes[J]. J Mol Neurosci. 2004;24(2):207-216.
[20] Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor-and cytokine-induced alterations of neuroplasticity[J]. Neuroscience. 2005;135(3):659-678.
[21] Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS.A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment[J]. Biol Psychiatry. 2007;61(5):661-670.
[22] Sanna, P P , Cammalleri, M, Berton, F,et al. Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region[J]. J.Neurosci. 2002,22(9), 3359-3365
[23] H Manev, T Uz, N R Smalheiser, R Manev.Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro[J].Eur. J. Pharmacol. 2001 411 (1-2):67-70
[24] BL Jacobs, H Praag, F H Gage.Adult brain neurogenesis and psychiatry: a novel theory of depression [J]. Mol. Psychiatry 2000,5 (3):262-269.
[25] SC Wright, J Zhong, J W Larrick.Inhibition of apoptosis as a mechanism of tumor promotion[J].FASEB J. 1994,8 (9):654-660.
[26] D Peer, Y Dekel, D Melikhov, R Margalit.Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models[J].Cancer Res. 200,464 (20):7562-7569.
[27] R Manev, T Uz, H Manev.Fluoxetine increases the content of neurotrophic protein S100 beta in the rat hippocampus[J].Eur. J.Pharmacol. 2001,420(2-3): R1-R2.
[28] M E Maragnoli, F Fumagalli, M Gennarelli, G Racagni, M A Riva.Fluoxetine and olanzanpine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain[J]. Biol. Psychiatry 2004,55 (11): 1095 - 1102.
[29] E Nahon, A. Israelson, S Abu-Hamad, S B Varda.Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death[J]. FEBS Lett. 2005,579(22):5105-5110.
[30] Y F Li, Y Z Zhang, YQ Liu,et al.Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice[J]. Acta Pharmacol. Sin. 2004,25(11): 1408-1412.
[31] Datta SR,Brunet A,Greenberg M E.Cellular survival:a play in three Akts[J]. Genes Dev, 1999,3(22) :2905-2927
[32] Downward, J. Mechanisms and consequences of activation of protein kinase B/Akt[J]. Curr Opin Cell Biol. 1998,10(2).262-267
[33] Alessi, D R, James, S R, Sownes, C P,et al.Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha [J]. Curr. Biol. 1997,7(4):261-269
[34] Andjelkovic, M, Maira, S M, Cron, P,et al. Domain Swapping Used To Investigate the Mechanism of Protein Kinase B Regulation by 3-Phosphoinositide-Dependent Protein Kinase 1 and Ser473 Kinase[J].Molecular and Cellular Biology Mol. Cell. Biol. 1999,19(7):5061-5072
[35] Yano S, Tokumitsu H, Soderling T R.Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway[J].Nature,1998; 396(6711):584-587
[36] del Peso, L, Gonzalez-Garcia, M, Page, C,et al.Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt[J]. Science, 1997, 278 (5338):687-689
[37] Datta, S R, Dudek, H, Tao, X,et al.Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery[J].Cell ,1997, 91(2):231-241
[38] Cardone, M H, Roy, N, Stennicke, H R, et al.Regulation of Cell Death Protease Caspase-9 by Phosphorylation [J].Science,1998, 282(5392): 1318-1321
[39] Cross, D A E, Alessi, D R, Cohen, P,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B[J].Nature 1995,378,785-789
[40] Pop M and Cooper GM.Role of glycogen synthase kinase 3 in the phosphadylinositol 3 kinase/Akt cell survival pathway[J]J Biol Chem, 1998,273(32): 19929-19932
[41] Kennedy SG,Kandel ES,Cross TK,et al.Akt/protein kinase B inhibits cell death by preventing the release cytochrome C from mitochondria[J]. Molecular and Cellular Biology, Mol Cell Biol, 1999,19(8):S800-S810.
[42] Brunet A,BonniA,Zigmond MJ,et al.Akt promotes cell survival by phosphorylating and inhibiting a Forkead transcription factor[J].Cell,1999,96(3):857-868.
[43] Frebel, K, and Wiese, S. Signalling molecules essential for neuronal survival and differentiation[J]. Biochem. Soc. Trans. 2006,34(Pt6):1287-1290
[44] Kelly, A, and Lynch, M A. Long-term potentiation in dentate gyrus of the rat is inhibited by the phosphoinositide 3-kinase inhibitor, wortmannin[J]. Neuropharmacology ,2000,39 (4):643-651
[45] Raymond, C R, Redman, S J, and Crouch, M F. The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons[J]. Neuroscience 2002,109(3):531-536
[46] Barros, D M, Mello e Souza, T, de Souza, M M, et al.LY294002, an inhibitor of phosphoinositide 3-kinase given into rat hippocampus impairs acquisition, consolidation and retrieval of memory for one-trial step-down inhibitory avoidance[J]. Behav. Pharmacol. 2001,12(8):629-634
[47] Mizuno, M, Yamada, K, Takei, N, et al.Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation[J]. Mol. Psychiatry 2003, 8(2):217-224
[48] Horwood, J M, Dufour, F, Laroche, S, and Davis, S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat[J]. Eur. J. Neurosci. 2006,23 (12):3375-3384
[49] Lin, C H, Yeh, S H, Lin, C H,et al. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala [J].Neuron 2001,31(5):841-851
[50] Chen, X, Garelick, M G., Wang, H,et al.PI3 kinase signaling is required for retrieval and extinction of contextual memory [J].Nat. Neurosci. 2005,8(7):925- 931
[51] Man, H Y, Wang, Q, Lu, W Y,et al.Wymann,M P, MacDonald, J F, and Wang, Y T. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons[J]. Neuron 2003,38(4):611-624
[52] Perkinton, M S, Ip, J K, Wood, G. L,et al. Phosphatidylinositol 3-kinase is a central mediator of NMD A receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones[J]. J. Neurochem. 2002,80(2):239-254
[53] Cammalleri, M, Lutjens, R, Berton, F, et al.Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1[J]. Proc. Natl. Acad. Sci. U. S. A. 2003,100(24): 14368-14373
[54] Schaeffer HJ,Weber MJ.Mitogen-activated protein kinases: specific messages from ubiquitous messengers[J].Mol.Cell. Biol.l999,19(4):2435-2444
[55] Philippe Lenormand, Jean-Marc Brondello, Anne Brunet, et al. Growth Factor-induced p42/p44 MAPK Nuclear Translocation and Retention Requires Both MAPK Activation and Neosynthesis of Nuclear Anchoring Proteins[J]. Cell Biol. 1998 August 10; 142(3):625-633
[56] Houslay MD, Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling[J]. Mol. Pharmacol. 2000,58(4):659-668
[57] Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function[J].Annu Rev Neurosci ,2001,24:677-736.
[58] Marinissen MJ, Gutkind JS.G-protein-coupled receptors and signaling networks: emerging paradigms[J].Trends Pharmacol Sci ,2001,22(7):368-376.
[59] Dawson TM, Ginty DD.CREB family transcription factors inhibit neuronal suicide[J]. Nat Med .2002,8(5):450-451.
[60] Weeber EJ,Sweatt JD.Molecular neurobiology of human cognition[J].Neuron 2002,33(6):845-848.
[61] Frodin M, Gammeltoft S.Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction [J] .Mol Cell Endocrinol 1999,151(1-2):65-77.
[62] Karin M.The regulation of AP-1 activity by mitogen-activated protein kinases[J]. Philos Trans R Soc Lond B Biol Sci, 1996,351(1336): 127-134.
[63] Garrington, T P, Johnson G L.Organization and regulation of mitogen-activated protein kinase signaling pathways[J].Curr Opin Cell Biol. 1999,11 (2):211-218.
[64] Brunet A D,Roux P, Lenormand S,et al.Nuclear translocation of p42/p44 mitogen- activated protein kinase is required for growth factor-induced gene expression and cell cycle entry [J].EMBO J. 1999,18(3):664-674.
[65] Pages G, P Lenormand, G. L'Allemain,et al.Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation[J]. Proc Natl Acad Sci USA.1993,90(18):8319-8323
[66] Buckley S, B Driscoll, L Barsky,et al. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2 [J]. Am J Physiol 1999,277(1pt 1):L159-L166.
[67] Xia Z, Dickens M,Raingeaud J,et al. Opposing effects of ERK and JNK-p38 MAPKs on apoptosis[J]. Science 1995,270(5240): 1326-1331.
[68] Shakibaei M, Schulze-Tanzil G, de Souza P,et al.Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes[J].J.Biol.Chem. 2001,276(16): 13289-13294.
[69] Boucher M J, Morisset J, Vachon P H, Reed J C, Laine J, and Rivard N MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells[J].J Cell Biochem. 2000, 79 (3):355-369
[70] Desire L,Courtois Y, and Jeanny J C.Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal neuronal bcl-xL and bcl-2 expression through a fibroblast growth factor receptor 1- and ERK-dependent pathway [J]. J Neurochem. 2000,75(1):151-163
[71] Choi IJ, Kim JS, Kim JM, Jung HC, Song IS. Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells [J].Infect Immun. 2003,71(2):830-837.
[72] Zimmermann, S, and Moelling, K. Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)[J].Science 1999,286(5445):1741-1744
[73] Chen, D, Heath, V, O'Garra, A, Johnston, J, and McMahon, M. Sustained Activation of the Raf-MEK-ERK Pathway Elicits Cytokine Unresponsiveness in T Cells[J].The Journal of Immunology (J. Immunol).1999,163(11):5796-5805
[74] Sanchez-Margalet, V, Goldfine, I D, Vlahos, C J, and Sung, C K. Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002[J]. Biochem. Biophys. Res. Commun 1994,204(2):446-452
[75] Karin Moelling, Karen Schad, Magnus Bosse, et al.Regulation of Raf-Akt Cross-talk [J]. The journal of biological chemistry 2002,277(34):31099-31106
[1]Czeh B,Michaelis T,Watanabe T,et al.Stress-induced changes in cerebral metabolites,hippocampal volume,and cell proliferation are prevented by antidepressant treatment with tianeptine[J].Proc Natl Acad Sci USA,2001,98(22):12796-12801.
[2]Fossati P,Radtchenko A,Boyer P.Neuroplasticity:from MRI to depressive symptoms [J].Eur Neuropsychopharmacol,2004,14Supp 15:S503-510
[3]Sheline Y,Wang P,Gado M,et al.Hippocampal atrophy in recurrent major depression[J].Proc Natl Acad Sci USA,1996,93(9):3908-3913.
[4]Malberg JE,Eisch AJ,Nestler EJ,et al.Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus[J].The Journal of Neuroscience Neurosci 2000,20(24):9104-9110.
[5]Malberg JE,Schechter LE.Increasing hippocampal neurogenesis:a novel mechanism for antidepressant drugs[J].Currrnt Pharmaceutical Design,2005,11(2):145-155
[6]张黎明,李云峰,宫泽辉.神经元再生:抑郁症治疗的新策略[J].生理科学进展2005,36,(2):109-112.
[7]L Santarelli,M Saxe,C Gross,et al.Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants[J].Science 2003,301(5634):805-809.
[8]Bunney W E and Davis J M.Norepinephrine in depressive reactions.A review[J].Arch.Gen.Psychiatry 1965,13(6):483-494.
[9]A Cipriani,P Brambilla,T Furukawa,et al.Fluoxetine versus other types of pharmacotherapy for depression[J].Cochrane Database Syst.Rev.2005,19(4)CD004185.
[10]H J Lee,J W Kim,S V Yim,et al.Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats[J].Mol.Psychiatry 2001,6(6) 610,725-728.
[11]Huang,E J,Reichardt,L F.TRK receptors:roles in neuronal signal transduction[J].Annu.Rev.Biochem.2003,72,609-642.
[12]Einat,H,Manji,H K.Cellular plasticity cascades:genes-to-behavior pathways in animal models of bipolar disorder[J].Biol.Psychiatry 2006,59(12),1160-1171
[13]Coyle,J T,Duman,R S.Finding the intracellular signaling pathways affected by mood disorder treatments[J].Neuron 2003,38(2),157-160
[14]Manji,H K,Duman,R S.Impairments of neuroplasticity and cellular resilience in severe mood disorders:implications for the development of novel therapeutics[J].Psychopharmacol.Bull.2001,35(2):5-49.
[15]Kazanis,I,Giannakopoulou,M,Philippidis,H,Stylianopoulou,F.Alterations in IGF-I,BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration[J].Exp.Neurol.2004,186(2):221-234
[16] Schabitz,W R, Sommer, C, Zoder,W,et al.Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia[J]. Stroke 2000,31 (9):2212-2217
[17] Zhang, Y, Pardridge, W M.Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brainderived neurotrophic factor conjugated to a blood-brain barrier drug targeting system[J]. Stroke 2001,32(6): 1378-1384
[18] Larsson, E, Nanobashvili, A, Kokaia, Z, Lindvall, O.Evidence for neuroprotective effects of endogenous brain derived neurotrophic factor after global forebrain ischemia in rats[J]. J. Cereb. Blood Flow Metab. 1999,19(11), 1220-1228.
[19] Kokaia, Z, Nawa, H, Uchino, H,et al.Regional brain derived neurotrophic factor mRNA and protein levels following transient forebrain ischemia in the rat[J]. Brain Res. Mol. Brain Res. 1996,38(1):139-144.
[20] Xu, H, Chen, Z, He, J,et al.Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus[J]. Hippocampus 2006,16(6):551-559.
[21] Hayley, S, Poulter, M O, Merali, Z, Anisman, H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity[J]. Neuroscience 2005,135(3),659-678.
[22] Manji, H K, Chen, G. PKC, MAP kinases and the Bcl-2 family of proteins as long-term targets for mood stabilizers[J].Mol.Psychiatry 2002,7(Suppl 1):S46-S56.
[23] Shirayama, Y, Chen, A C, Nakagawa, S,et al. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression[J]. J. Neurosci. 2002,22(8):3251-3261.
[24] Einat, H, Yuan, P, Gould, T D,et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation[J]. J. Neurosci. 2003,23(19):7311-7316.
[25] Mercier, G, Lennon, A M, Renouf, B,et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes[J].J. Mol. Neurosci. 2004,24(2):207-216.
[26] Hayley, S, Poulter, M O, Merali, Z, Anisman, H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity[J]. Neuroscience 2005,135(3):659-678.
[27] Manji, H K, Moore, G J, Chen, G.Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness[J]. J. Clin. Psychiatry 2000,61 Suppl 9,82-96.
[28] Kuipers, S D, Bramham, C R.Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy[J]. Curr. Opin. Drug Discov.Devel. 2006,9(5):580-586.
[29] Siuciak, J A, Lewis, D R, Wiegand, S J, Lindsay, R M.Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)[J]. Pharmacol. Biochem. Behav. 1997, 56(1):131-137.
[30] Einat, H, Manji, H K. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder[J]. Biol.Psychiatry2006,59(12): 1160-1171.
[31] Chen, G., Manji, H K.The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers[J]. Curr. Opin. Psychiatry 2006, 19(3):313-323.
[32] Kalueff, A V, Avgustinovich, D F, Kudryavtseva, N N, Murphy, D L. BDNF in anxiety and depression[J]. Science 2006,312(5780):1598-1599.
[33] Einat H, Yuan P, Gould TD, et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation[J]. J Neurosci. 2003;23(19):7311 -7316.
[34] Airaksinen MS, Saarma M.The GDNF family: signaling, biological functions and therapeutic value[J]. Nat Rev Neurosci 2002,3(5):383-394
[35] Ducray A, Krebs SH, Schaller B,et al.GDNF-family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon[J] .Brain Res 2006,1069(1): 104-112
[36] Lin LF, Doherty DH, Lile JD,et al.GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons[J].Science 1993,260(5111): 1130-1132
[37] Sarabi A, Hoffer BJ, Olson L, Morales M. GFR alpha-1 is expressed in parvalbumin GABAergic neurons in the hippocampus[J]. Brain Res 2000,877(2): 262-670
[38] Cheng H, Fu YS, Guo JW. Ability of GDNF to diminish free radical production leads to protection against kainite-induced excitotoxicity in hippocampus[J]. Hippocampus 2004,14(1):77-86.
[39] Gratacos E, Pe'rez-Navarro E, Tolosa E, Arenas E, Alberch J. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members[J]. J Neurochem 2001,78(6):1287-1296.
[40] Quintero EM, Willis LM, Zaman V, et al.Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway[J].Neuroscience 2004,124(1): 137-146
[41] Pe'rez-Navarro E, Akerud P, Marco S, et al. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease[J]. Neuroscience 2000,98(1):89-96
[42] Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders[J]. Proc Natl Acad Sci USA 1998,95(2): 13290-13295.
[43] Frodl T, Meisenzahl EM, Zetzsche T, et al.Hippocampal changes in patients with a first episode of major depression[J].Am J Psychiatry 2002,159(7): 1112-1128.
[44] Rajkowska G. Post-mortem studies in mood disorders indicate altered numbers of neurons and glial cells[J]. Biol Psychiatry 2000,48(8):766-777
[45] Strelau J, Unsicker K. GDNF family members and their receptors:expression and functions in two oligodendroglial cell lines representing distinct stages of oligodendroglial development[J]. Glia 1999,26(4):291-301
[46] Tomac AC, Agulnick AD, Haughey N, et al. Effects of cerebral ischemia in mice deficient in Persephin[J]. Proc Natl Acad Sci U S A2002,99(14):9521-9526.
[47] Kitagawa H, Sasaki C, Zhang WR,et al.Induction of glial cell line-derived neurotrophic factor receptor proteins in cerebral cortex and striatum after permanent middle cerebral artery occlusion in rats[J]. Brain Res 1999,834(1-2):190-195
[48] Kokaia Z, Airaksinen MS, Nanobashvili A, et al. GDNF family ligands and receptors are differentially regulated after brain insults in the rat[J]. Eur J Neurosci 1999,11(4): 1202-1216
[49] Miyazaki H, Okuma Y, Fujii Y,et al.Glial cell line-derived neurotrophic factor protects against delayed neuronal death after transient forebrain ischemia in rats[J]. Neuroscience 1999,89(3):643-647
[50] Miyazaki H, Nagashima K, Okuma Y, Nomura Y. Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats[J]. Brain Res 2001,922(2): 165-172.
[51] Rosenblad C, Kirik D, Devaux B,et al.Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle[J]. Eur J Neurosci 1999,11(5): 1554-1566
[52] Rosenblad C, Kirik D, Bjo¨rklund A. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model[J]. Exp Neurol 2000,161(2):503-516
[53] Rossi J, Luukko K, Poteriaev D, et al. Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR2, a functional neuroturin receptor[J].Neuron 1999,22(2):243-252
[54] Stromberg I, Bjorklund L, Johansson M, et al. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo[J]. Exp Neurol 1993,124(2):401 -412
[55] Tseng JL, Bruhn SL, Zurn AD, Aebischer P. Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy[J]. Neuroreport 1998,9(8): 1817-1822
[56] Takebayashi M, Hisaoka K, Nishida A, et al. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorder[J]. Int J Neuropsychopharmacol 2006,9(5):607-612.
[57] Rosa AR, Frey BN, Andreazza AC, et al. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder[J]. Neurosci Lett 2006,407(2): 146-150
[58] Chen ACH, Eisch AJ, Sakai N,et al.Regulation of GFR a-1 and a-2 mRNAs in rat brain by electroconvulsive seizure[J]. Synapse 2001,39(1):42-50
[59] Hisaoka K, Nishida A, Koda T, et al.Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioma cells[J]. J Neurochem 2001;79(1):25-34.
[60] Hisaoka K, Takebayashi-M, Tsuchioka M,et al. Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells[J]. J Pharmacol Exper Therap 2007,321(1): 148-157.
[61] Hisaoka K, Maeda N, Tsuchioka M, Takebayashi M. Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production[J]. Brain Res 2008,1196:53-58.
[62] Mercier G, Lennon AM, Renouf B, et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes[J]. J Mol Neurosci 2004,24(2):207-216.
[63]Michel T M, Frangou S, Camara S,et al.Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: A comparative post-mortem study[J].Eur Psychiatry 2008,23(6):413-420.
[64] Banner LR, Patterson PH.Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia[J]. Proc Natl Acad Sci USA1994, 91(15):7109-7113.
[65] Banner LR, Moayeri NN, PattersonPH. Leukemia inhibitory factor is expressed in astrocytes following cortical brain injury[J]. Exp Neurol 1997,147(1): 1-9.
[66] Jankowsky JL, Patterson PH.Differential regulation of cytokine expression following pilocarpine-induced seizure[J]. Exp Neurol 1999,159(2):333-346
[67] Suzuki S, Tanaka K, Nogawa S, et al.Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats[J]. J Cereb Blood Flow Metab 2000,20(4):661- 668.
[68] Minami M, Maekawa K, Yamakuni H, et al.Kainic acid induces leukemia inhibitory factor mRNA expression in the rat brain: differences in the time course of mRNA expression between the dentate gyrus and hippocampal CA1/CA3 subfields[J]. Brain Res Mol Brain Res 2002,107(1):39-46.
[69] Bauer S, Rasika S, Han J,et al.Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium[J]. J Neurosci 2003,23(5): 1792-1803
[70] Sriram K, Benkovic SA, Hebert MA,et al. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the l-methyl-4- phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?[J]. J BiolChem2004,279(19): 19936-19947.
[71] Rao MS, Sun Y, Escary JL, et al.Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons[J].Neuron 1993,11(6): 1175-1185.
[72] Corness J, Shi TJ, Xu ZQ, Brulet P, Hokfelt T.Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy[J]. Exp Brain Res 1996,112(1):79-88.
[73]Sun Y, Zigmond RE.Leukaemia inhibitory factor induced in the sciatic nerve after axotomy is involved in the induction of galanin in sensory neurons[J].Eur J Neurosci 1996,8(10):2213-2220.
[74] Holmberg KH, Patterson PH.Leukemia inhibitory factor is a key regulator of astrocytic, microglial and neuronal responses in a low-dose pilocarpine injury model[J]. Brain Res 2006,1075(l):26 -35.
[75]Sugiura S, Lahav R, Han J,et al.Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro[J]. Eur J Neurosci 2000, 12(2):457-466.
[76]Kerr BJ, Patterson PHPotent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse[J]. Exp Neurol 2004,188(2):391-407.
[77]Kerr BJ, Patterson PH.Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury[J]. Glia 2005,51(1):73-79.
[78] Bauer S, Patterson PH.The cell cycle-apoptosis connection revisited in the adult brain[J]. J Cell Biol 2005,171(4):641- 650.
[79] Bonni A, Sun Y, Nadal-Vicens M,et al.Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway[J].Science 1997,27(5337)8:477-483.
[80] Molne M, Studer L, Tabar V,et al.Early cortical precursors do not undergo LIF-mediated astrocytic differentiation[J].J Neurosci Res 2000,59(3):301-311.
[81] Viti J, Feathers A, Phillips J, Lillien L.Epidermal growth factor receptors control competence to interpret leukemia inhibitory factor as an astrocyte inducer in developing cortex[J]. J Neurosci 2003,23(8):3385-3393
[82] Chang MY, Park CH, Son H, Lee YS, Lee SH.Developmental stage dependent self-regulation of embryonic cortical precursor cell survival and differentiation by leukemia inhibitory factor[J]. Cell Death Differ 2004,11(9):985-996.
[83]Barnabe-Heider F, Wasylnka JA, Fernandes KJ,et al.Evidence that embryonic neurons regulate the onset of cortical gliogenesis via cardiotrophin-1 [J].Neuron 2005,48(2):253-265.
[84] He F, Ge W, Martinowich K,et al.A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis[J].Nat Neurosci 2005,8(5):616-625.
[85] Williams RL, Hilton DJ, Pease S,et al.Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells[J].Nature 1988,336(6200):684-687.
[86]Wright LS, Li J, Caldwell MA,et al.Gene expression in human neural stem cells: effects of leukemia inhibitory factor[J]. J Neurochem 2003,86(1): 179 -195.
[87] Shimazaki T, Shingo T, Weiss S.The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells[J]. J Neurosci 2001,21(19):7642-7653.
[88] Pitman M, Emery B, Binder M,et al.LIF receptor signaling modulates neural stem cell renewal[J].Mol Cell Neurosci 2004,27(3):255-266.
[89] Bonaguidi M A, McGuire T, Hu M,et al.LIF and BMP signaling generate separate and discrete types of GFAP expressing cells[J]. Development 2005,132(24):5503-5514.
[90] Gregg C, Weiss S.CNTF/LIF/gp 130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain[J]. Development 2005,132(2):565-578
[91] Chojnacki A, Shimazaki T, Gregg C, Weinmaster G, Weiss S.Glycoprotein 130 signaling regulates Notch 1 expression and activation in the self-renewal of mammalian forebrain neural stem cells[J]. J Neurosci 2003,23(5):1730 -1741.
[92] Sylvian Bauer and Paul H. Patterson. Leukemia inhibitory factor promotes neural stem cell self-renewal in the adult brain[J]. J Neurosci (The Journal of Neuroscience), 2006 ,26(46): 12089 -12099
[93] Lemke R, Gadient R A, Schliebs R, Bigl V, Patterson P H .Neuronal expression of leukemia inhibitory factor (LIF) in the rat brain[J]. Neurosci Lett 1996,215(3): 205-208.
[94] Gadient R A, Lein P, Higgins D, Patterson P H. Effect of leukemia inhibitory factor (LIF) on the morphology and survival of cultured hippocampal neurons and glial cells[J]. Brain Res 1998,798(1-2):140-146.
[95] Auernhammer C J, Melmed S. Leukemia-inhibitory factor neuroimmune modulator of endocrine function[J]. Endocrine Rev 2000,21(3): 313-345.
[96] Pechnick R N,Chesnokova V M,Kariaqina A,et al. Reduced immobility in the forced swim test in mice with a targeted deletion of the leukemia inhibitory factor (LIF) gene[J].Neuropsychopharmacology. 2004,29(4):770-776.
[97]Herr I,Debatin K.Cellular stress response and apoptosisin cancer therapy[J].Blood, 2001,98(9):2603-2604.
[98] Desagher S,Osensand A,Nichols A,et al.Bidinduced conformational change of Bax is responsible fo rmitochondrial cytochrome C release during apoptosis[J].J Cell Biol,1999, 144(3):891-901.
[99] Gross A,Mcdonneu M J,Korsmeyer S J,et al.Bcl-2 family members and mitochondria in apoptosis[J].GenDev,1999,13(2): 1899-1911.
[100] Myers KM, Fiskum G, Liu Y, Simmens S J, Bredesen D E, Murphy A N. Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability[J]. J Neurochem 1995,65(6):2432-2440
[101] Manakova S, Puttonen KA, Raasmaja A, Mannisto P T. The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA -induced toxicity[J].Toxicol Lett 2004,154( 1-2): 117-123.
[102] Rolletschek A, Chang H, Guan K,et al.Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors[J]. Mech Dev2001,105(1-2): 93-104.
[103] Bachmann RF, Schloesser RJ, Gould TD, Manji HK.Mood stabilizerstarget cellular plasticity and resilience cascades: implications for the development of novel therapeutics[J]. Mol Neurobiol,2005,32(2): 173-202.
[104] Hayley S, Poulter MO, Merali Z, Anisman H.The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity[J]. Neuroscience 2005,135(3): 659-678.
[105] Arakawa, Y, Sendtner, M, Thoenen, H.Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines[J].J. Neurosci. 1990.10(11):3507-3515.
[106] Forger, N G, Roberts, S L, Wong, V, Breedlove, S M.Ciliary neurotrophic factor maintains motoneurons and their target muscles in developing rats[J]. J. Neurosci. 1993,13(11):4720-4726.
[107] Forger, N G, Wagner, C K, Contois, M,et al.Ciliary neurotrophic factor receptor alpha in spinal motoneurons is regulated by gonadal hormones[J]. J. Neurosci. 1998,18(21):8720-8729
[108] Masu, Y, Wolf, E, Holtmann, B,et al.Disruption of the CNTF gene results in motor neuron degeneration[J]. Nature 1993,365(6441):27-32.
[109] Takahashi, R, Yokoji, H, Misawa, H,et al.A null mutation in the human CNTF gene is not causally related to neurological diseases[J].Nat. Genet.l994,7(1):79-84.
[110] Gelernter, J, Van Dyck, C, van Kammen, DP, et al.Ciliary neurotrophic factor null allele frequencies in schizophrenia, affective disorders, and Alzheimer's disease[J].Am. J.Med.Genet. 1997,74(5):497-500.
[111] Gelernter, J, Kranzler, H, Lacobelle, J.Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF))[J].Genomics 1998,52(3):289-297.
[112] Orrell, RW, King, A W, Lane, R J,et al.Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis[J].J. Neurol. Sci. 1995, 132 (2): 126-128.
[113] Thome, J, Durany, N, Harsanyi, A, et al.A null mutation allele in the CNTF gene and schizophrenic psychoses[J]. NeuroReport 1996,7(8): 1413-1416.
[114] Thome, J, Kornhuber, J, Baumer, A,et al.Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases? [J].Neurosci. Lett. 1996,203(2): 109-110.
[115] Thome, J, Jonsson, E, Foley, P,et al.Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish population. Psychiatr[J].Genet.1997,7(2):79-82.
[116] Bloch, J, Bachoud-Levi, AC, Deglon N, et al. Neuroprotective Gene Therapy for Huntington's Disease,Using Polymer- Encapsulated Cells Engineered to Secrete Human Ciliary Neurotrophic Factor: Results of a Phase I Study[J]. Hum Gene Ther 2004,15(10):968-75.
[117] Grünblatt E, Hupp E, Bambula M,et al.Association study of BDNF and CNTF polymorphism to depression in non-demented subjects of the "VITA" study[J]. 2006,96(1-2):111-116.
[118] Barres B A, Hart I K, Coles H S,et al. Cell death and control of cell survival in the oligodendrocyte lineage[J]. Cell 1992,70(1):31-46.
[119] Barres B A, Schmid R, Sendnter M and Raff M C.Multiple extracellular signals are required for long-term oligodendrocyte survival[J].Development 1993,118 (1):283-295.
[120] Carson M J, Behringer R R, Brinster R L and McMorris-F A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice[J].Neuron 1993,10(4):729-740.
[121] Zumkeller W. The effect of insulin-like growth factors on brain myelination and their potential therapeutic application in myelination disorders[J]. Eur. J. Paediatr. Neurol.1997,1(4):91-101.
[122] Ye P, Lee K H and D'Ercole A J. Insulin-like growth factor-I(IGF-I) protects myelination from undernutritional insult: studies of transgenic mice overexpressing IGF-I in brain[J]. J. Neurosci. Res. 2000,62(5):700-708.
[123] Guan J, Bennet L, George S,et al.Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep[J]. J. Cereb. Blood Flow Metab. 2001,21(5):493-502.
[124] Lin S, Fan L W, Pang Y,et al. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat[J]. Brain Res. 2005,1063(1):15-26.
[125] Cao Y, Gunn A J, Bennet L,et al.Insulin-like growth factor (IGF)-l suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep[J]. J. Cereb.Blood Flow Metab. 2003, 23 (6):739-747.
[126] Mason J L, Xuan S, Dragatsis I, Efstratiadis A and Goldman J E. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination[J]. J. Neurosci. 2003,23(20):7710-7718.
[127] Yao D L, Liu X, Hudson L D and Webster H D. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis[J]. Proc. Natl Acad. Sci. USA 1995,92(13):6190-6194.
[128] Webster H D.Growth factors and myelin regeneration in multiple sclerosis[J].Mult. Scler. 1997,3(2): 113-120.
[129] Ye P and D'Ercole A J. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury[J].Endocrinology 1999,140(7):3063-3072.
[130] Ness J K and Wood T L. Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis[J]. Mol. Cell. Neurosci. 2002,20(3):476-488
[131] Cui Q L, Zheng W H, Quirion R and Almazan G Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival[J]. J. Biol. Chem. 2005,280(10): 8918-8928.
[132] McMorris F A, Smith T M, DeSalvo S and Furlanetto R W. Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development[J]. Proc. Natl Acad. Sci. USA 1986,83(3):822-826
[133] McMorris F A and Dubois-Dalcq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro[J]. J. Neurosci. Res. 1988,21(2-4): 199-209
[134] Masters B A,Werner H, Roberts C T Jr, LeRoith D and Raizada M K. Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains[J]. Regul. Pept. 1991,33(2): 117-131.
[135] Bhat N R, Hauser K F and Kindy M S. Cell proliferation and protooncogene induction in oligodendroglial progenitors[J]. J. Neurosci.Res. 1992,32(3):340-349.
[136] van der Pal R H, Koper J W, van Golde L M and Lopes-Cardozo M. Effects of cultures[J]. J. Neurosci. Res. 1988,19(4):483-490.
[137] Mozell R L and McMorris F A.Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures[J]. J. Neurosci.Res. 1991,30(2):382-390
[138] Yao D L, Liu X, Hudson L D and Webster H D. Insulin-like growth factor-I given subcutaneously reduces clinical deficits,decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis[J]. Life Sci 1996,58 (16): 1301-1306.
[139] Dubois-Dalcq M and Murray K.Why are growth factors important in oligodendrocyte physiology?[J]. Pathol. Biol. (Paris) 2000.48(1):80-86.
[140] Clemmons D R and Maile L A. Minireview: integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling[J]. Endocrinology 2003,144(5): 1664-1670.
[141] Dupont J, Pierre A, Froment P and Moreau C. The insulin-like growth factor axis in cell cycle progression[J]. Horm. Metab. Res. 2003,35(11-12):740-750.
[142] Khawaja X,Xu J, Liang J J, Barrett J E.Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: impliations for depressive disorders and future therapies[J]. J Neurosci Res 2004;75(4): 451-460.
[143] Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors[J]. Physiol Rev 1996;76(4):1005-1026.
[144] Anlar B, Sullivan KA, Feldman EL.Insulin-like growth factor-I and central nervous system development[J]. Horm Metab Res 1999;31 (2-3): 120-125.
[145] D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G The role of insulin like growth factors in the central nervous system[J]. Mol Neurobiol 1996;13(3):227- 255.
[146] Cohick W, Clemmons DR. The insulin-like growth factors[J]. Annu Rev Physiol 1993;55:131-153.
[147] Dumana C H,Schlesingera L,Terwilligera R,et al.Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise[J].Behzv Brain Res. 2009,198(2):366-71.
[1]杨德森.行为医学[M].湖南科学技术出版社.1999,400.
[2]李焕德,彭文兴.抑郁症药物治疗新进展[J].国外医学,精神病学分册,1997,24(3):129-133.
[3]Bunney W.E and Davis J.M.Norepinephrine in depressive reactions.A review.Arch[J].Gen.Psychiatry 1965,13(6):483-494.
[4]Sehildkraut J J.The catecholamine hypothesis of affective disorders.A review of supportive evidence[J].Int.J.Psychiatry 1967,4(3):203-217.
[5]Czeh B,Michaelis T,Watanabe T,et al.Stress-induced changes in cerebral metabolites,hippocampal volume,and cell proliferation are prevented by antidepressant treatment with tianeptine[J].Proc Natl Acad Sci USA,2001,98(22):12796-12801.
[6]Fossati P,Radtchenko A,Boyer P.Neuroplasticity:from MRI to depressive symptoms [J].Eur Neuropsychopharmacol,2004,14Suppl 5:S503-510
[7]Sheline Y,Wang P,Gado M,et al.Hippocampal atrophy in recurrent major depression[J].Proc Natl Acad Sci USA,1996,93(9):3908-3913.
[8]Yvette I,Sheline,Milan S,et al.Depression duration but not age predicts hippocampal volume loss in medically healthy woman with recurrent major depression[J].Neurosci,1999,19(12):5034-5043.
[9]Duman RS,Malberg J,Nakagawa S,et al.Neuronal plasticity and survival in mood disorders[J].Biol Psychiatry,2000,48(8):732-739.
[10]Duman RS,Malberg JE,Nakagawa S,et al.Regulation of adult neurogenesis by psychotropic drugs and stress[J].Pharmacol Exp Ther 2001,299(2):401-407.
[11]Benninghoff J Schmitt A,Mossner R,et al.When cells become depressed focus on neural stem cells in novel treatment strategies against depression[J].J Neural Transm,2002,109(5-6):947-962.
[12]Kempeman G.Regulation of adult hippocampal neurogenes implication for novel theories of major depression[J].Bipolar Disord,2002,4(1):17-23
[13]Malberg JE,Eisch AJ,Nestler EJ,et al.Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus[J].J Neurosci 2000,20(24):9104-9110.
[14]Malberg JE,Schechter LE.Increasing hippocampal neurogenesis:a novel mechanism for antisepressant drugs[J].Currrnt Pharmaceutical Design,2005,11(2):145-155
[15]朱兴族,罗质璞.抑郁症发病机制及治疗药物.神经药理学新论.[M]北京:人民卫生出版社,第一版,2004:1-20.
[16]张黎明,李云峰,宫泽辉.神经元再生:抑郁症治疗的新策略[J].生理科学进展,2005,36(2):109-112.
[17]Luca Santarelli,Michael Saxe,Cornelius Gross,et al.Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants[J].Science 2003.301(5634):805-809
[18]Duman RS,Nakagawa S,Malberg J.Regulation of adult neurogenesis by antidepressant treatment[J].Neuropsychopharmacology 2001,25(6):836-844.
[19]Gould E,Tanapat P,Rydel T,Hastings N.Regulation of hippocampal neurogenesis in adulthood[J].Biol Psychiatry 2000,48(8):715-720.
[20]Shors TJ,Miesegaes G,Beylin A,Zhao M,Rydel T,Gould E.Neurogenesis in the adult is involved in the formation of trace memories[J].Nature 2001,410(6826):372-376.
[21]Czeh B,Michaelis T,Watanabe T et al.Stress-induced changes in cerebral metabolites,hippocampal volume,and cell proliferation are prevented by antidepressant treatment with tianeptine[J].Proc Natl Acad Sci USA 2001,98(22):12796-12801.
[22]Palmer T,Takahashi J,Gage FH.The adult rat hippocampus contains primordial neural stem cells[J].Mol Cellular Neuroscience 1997,8(6):389-404.
[23]Gould E,Reeves AJ,Graziano MSA,Gross CG.Neurogenesis in the neocortex of adult primates[J].Science 1999,286(5439):548-552.
[24]Gould E,Vail N,Wagers M,Gross CG.Adult generated hippocampal and neocortical neurons in macaques have a transient existence[J].Proc Natl Acad Sci USA 2001;98(19):10910-10917.
[25]李云峰,刘艳芹,张有志等.抗抑郁剂对慢性应激小鼠海马神经元再生的影响[J].中国药理学通报,2004,20:385-388.
[26]Hellsten J,Wennstrom M,Mohapel P,Ekdahl CT et al.Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment[J].Eur J Neurosci,2002,16(2):283-290
[1]Ahmed S,Reynold BA,Weiss S.BDNF enhances the differentiation but not the survival of CNS stem cell-derived neuronal precursors[J].J Neurosci.1995,15(8):5765-5778
[2]Shetty AS,Turner DA.In vitro survival and differentiaton of neurons derived from epidenmal growth factor-responsive postnatal hippocampal stem cells:including effects of brain derived neurotrophic factor[J].J.Neurobiol.1998,35(4):395-425.
[3]Goldman SA,Luskin MB.Strategies utilized by migration neurons of the postnatal vertebrate forebrain[J].J.Trends Neurosci.1998,21(3):107-114
[4]Smith MA,Makina S,Kvetnansky R,et al.Stress and glucocorticoids affect the expressing of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus[J].J.Neurosci,1995,15(3 Pt 1):1768-1777.
[5]Siuciak JA,Lewis DR,Weiegand SJ et al.Antideprssan-dike effect of brain derived neurotrophic factor[J].Parmacol Biochem Behav,1997,56(1):131-137.
[6]Ueyama T,Kawai Y,Nemoto K,et al.Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain[J].Neurosci Res,1997,28(2): 103-110.
[7]Nibuya M,Morinobu S,Duman RS.Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments[J].J Neurosci 1995,15(11):7539-7547.
[8]Russo-Neustadt A,Beard RC,Cotman CW.Exercise,antidepressant medications,and enhanced brain derived neurotrophic factor expression[J].Neuropsycho-pharmacology 1999,21(5):679-682.
[9]Russo-Neustadt A,Ha T,Ramirez R,Kesslak JP.Physical activity-antidepressant treatment combination:impact on brain-derived neurotrophic factor and behavior in an animal model.Behav Brain Res 2001,120(1):87-95.
[10]Altar CA.Neurotrophins and depression[J].Trends Pharmacol Sci.1999,20(2):59-61.
[11]Chen B,Dowlatshahi D,MacQueen GM,Wang JF,Young LT.Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication[J].Biol Psychiatry 2001,50(4):260-265.
[12]Poo MM.Neurotrophins as synaptic modulators[J].Nat Rev Neurosci 2001,2(1):24-32.
[13]Lin LF,Doherty DH,Lile JD,Bektesh S,Collins F.GDNF:a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons[J].Science 1993;260(5111):1130-1132.
[14]Hisaoka K,Nishida A,Koda T et al.Antidepressant drug treatments induce glial cell line-derived neurotrophic factor(GDNF) synthesis and release in rat C6glioblastoma cells[J].J Neurochem 2001,79(1):25-34.
[15]Chen AC,Eisch AJ,Sakai N,Takahashi M,Nestler EJ,Duman RS.Regulation of GFR alpha-1 and GFR alpha-2 rnRNAs in rat brain by electroconvulsive seizure[J].Synapse 2001,39(1):42-50.
[16]王雪琦,山振东,赵小林,等.抑郁症大鼠海马和顶叶皮质神经元NGF含量及其mRNA的表达[[J].第二军医大学学报,2002,23(6):590-592
[17]王雪琦,路长林,孙学军,等.侧脑室微量注射神经生长因子对实验性抑郁症 大鼠抑郁行为和海马神经元损伤的影响[J].中国行为医学科学,2002,11(6):481-484.
[18]李春元,李梓.抗抑郁新药的临床研究进展[J].国外医药-合成药、生化药、制剂分册,2001,22(3):276-279.
[19]Shaywitz A,Greenberg M.CREB:a stimulus-induced transcription factor activated by a diverse array of extracellular signals[J].Annu Rev Biochem 1999,68:821-861.
[20]Lambert HW,Weiss ER,Lauder JM.Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells[J].Dev Neurosci 2001,23(1):70-77.
[21]Bonni A,Brunet A,West AE,Datta SR,Takasu MA,Greenberg ME.Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms[J].Science 1999,286(5443):1358-1362.
[22]Riccio A,Ahn S,Davenport CM,Blendy JA,Ginty DD.Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons[J].Science 1999,286(5448):2358-2361.
[23]Yuan J,Yankner BA.Apoptosis in the nervous system[J].Nature 2000,407(6805):802-809.
[24]Poo MM.Neurotrophins as synaptic modulators[J].Nat Rev Neurosci 2001,2(1):24-32.
[25]Kohara K,Kitamura A,Morishima M,Tsumoto T.Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons[J].Science 2001,291(5512):2419-2423.
[26]Shaywitz A,Greenberg M.CREB:a stimulus-induced transcription factor activated by a diverse array of extracellular signals[J].Annu Rev Biochem 1999,68:821-861.
[27]Drevets WC.Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression[J].Prog Brain Res 2000,126:413-431.
[28]Yu-Yin Huang,Chi-Hsien Peng,Yi-Ping Yang,et al.Desipramine Activated Bcl-2 Expression and Inhibited Lipopolysaccharide-Induced Apoptosis in Hippocampus -Derived Adult Neural Stem Cells[J].J Pharmacol Sci 2007,104(1):61-72
[29]Chi-Hsien Peng,Shih-Hwa Chiou,Shih-Jen Chen,et al.Neuroprotection by Imipramine against lipopo|ysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway[J].Eur Neuropsychopharmacol 2008,18(2):128-140
[30]Shih-Hwa Chiou,Hung-Hai Ku,Tung-Hu Tsai,et al.Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway[J].Br J Pharmacol 2006,148(5):587-598
[31]Wachtel H.The second-messenger dysbalance hypothesis of affective disorders [J].Pharmacopsychiatry,1990,23(1):27-32
[32]金光亮,周东丰,郭霞珍,等.慢性利血平抑郁模型大鼠脑内游离钙离子、钙调素和环核苷酸含量的变化[J].中华精神科杂志,1997,30(2):67-69
[33]Hsiung SC,Adlersberg M,Arango V,et al.Attenuated 5-HT1A receptor signaling in brains of suicide victims:involvement of adenylyl cyclase,phosphatidylinositol 3-kinase,Akt and mitogen-activated protein kinase[J].J Neurochem,2003,87(1):82-194
[34]Wachtel H.Potential antidepressant activity of rolipram and other seletive cyclic adenosine 3' 5'-monophosphate phosphodiesterase inhibitors[J].Neuro-pharmacology,1983,22(3):267-272
[35]刘艳梅,祁红,陈红专.抗抑郁药的信号转导机制[J].中国临床药理学与治疗学,2004,9(12):1321-1326.
[36]王珍琦,刘光伟,龚守良.抗抑郁药的神经保护作用及其机制[J].吉林大学学报:医学版,2004,30(5):827-830.
[37]Duman RS.Pathophysiology of depression:the concept of synaptic plasticity[J].Eur Psychiatry,2002,17(Suppl 3):306-310
[38]Dowlatshahi D,MacQueen GM,Wang JF,et al.Increased temporal cortex CREB concentrations and antidepressant in major depression[J].Lancet,1998,352(9142): 1754-1755
[39] Koch JM, Kell S , Hinze-Selch D, Al denhoff JB.Changes in CREB- phosphorylation during recovery from major depression[J].J Psychiatr Res, 2002,36(6):369-375
[40] Yamada S, Yamamoto M, Ozawa H, Riederer P, Saito T.Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder[J].J Neural Transm, 2003,110(6):671-680
[41] Nibuya M, Nestler EJ, Duman RS.Chronic, antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus[J]. JNeurosci ,1996,16(7):2365-2372
[42] Thome "J,Sakai N,Shin K,et al.cAMP response element-mediated gene transcription is upregulated by chronic antidepressant[J].J Neurosci, 2000,20(11):4030-4036
[43] Downward J.Signal transduction. Regulating S6 kinase[J].Nature, 1994,371(6496): 378-379.
[44] Siren AL Ehrenreich H.Erythropoietin a novel concept for neuroprotection [J].Eur Arch Psychiatry Clin Neurosci ,2001,251(4): 179-184
[45] Dudek H,Datta S R,Franke T F, et al.Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt[J].Science,1997,275(5330):661-665
[46] Widmann C ,Gibson S,Johnson G L.Caspase-dependent Cleavage of Signaling Proteins during Apoptosis[J].J Biol Chem, 1998,273(12):7141-7147
[47] Eves EM , Xiong W, Bellacosa A, et al.Akt, a Target of Phosphatidylinositol 3-Kinase, Inhibits Apoptosis in a Differentiating Neuronal Cell Line[J]. Mol Cell Biol, 1998,18(4):2143-2152
[48] Burgering BMT, Coffer P J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction[J] .Nature 1995, 376(6541):599-602
[49] Philpott KL,McCarthy M J, Klippel A, et al.Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons[J].J. Cell Biol,1997,139(3):809-815
[50] Yamashita K, Kajstura J, Discher D J, et al.Reperfusion-Activated Akt Kinase Prevents Apoptosis in Transgenic Mouse Hearts Overexpressing Insulin-Like Growth Factor-l[J].Circ Res,2001,88(6):609-614
[51] Datta SR,Brunet A,Greenberg M E.Cellular survival: a play in three Akts[J].Genes Dev,1999,13(22):2905-2927
[52] Yano S, Tokumitsu H, Soderling T R.Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway[J]. Nature, 1998,396 (6711):584-587
[53] Stephens L,Anderson K,Stokoe D,et al.Protein kinaseB Kinase that mediate phosphatidylinosiol 3,4,5-trisphosphate-activation of protein kinaseB [J].Science, 1998,279(5351):710-714.
[54] Pap M,and Coopes GM.Role of glycogen synthase kinase-3 in the phosphadylinositol3-kinase/Akt cell survival pathway[J].J Biol Chem,1998, 273(32):19929-19932
[55] Kennedy SG,Kandel ES,Cross TK,et al.Akt/protein kinase B inhibits cell death by preventing the release cytochrome C from mitochondria[J].Mol Cell Biol, 1999,19(8):5800-5810.
[56] Brunet A,Bonni A,Zigmond M J,et al.Akt promotes cell survival by phosphorylat- ing and inhibiting a Forkead transcription factor[J].Cell,1999,96(6):857-868.
[57] Rabincvitch A,Suarez-pinzon W,Strynadka K,et al.Transfection of human pancreatic islets with an anti-apoptotic gene(bcl-2) protects beta-cells from cytokine induced destruction[J].Diabetes,1999,48(6):1123-1129.
[58] Yano S,ToKumitsu H,Soderling TR.Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway[J] .Nature, 1998, 396 (6711):584-587.
[59] Schaeffer HJ,Weber MJ.Mitogen-activated protein kinases: specific messages from ubiquitous messengers[J].Mol.Cell. Biol. 1999,19(4):2435-2444
[60] Houslay MD, Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling[J].Mol.Pharmacol. 2000, 58(4):659-668
[61] Adams JP, Sweatt JD. Molecular psychology: roles for the ERK MAP kinase cascade in memory[J].Annu.Rev.Pharmacol.Toxicol.2002,42:135-163
[62] Adams JP, Roberson ED, English JD, Selcher JC, Sweatt JD.MAPK regulation of gene expression in the central nervous system[J].Acta Neurobiol Exp, 2000, 60(3):377-394
[63] Anderson NG,Maller JL,Tonks NK, Sturgill TW. Requirement for intergration of signals from two distinct phosphorylation pathways for activation of MAP kinase[J].Nature,1990,343(6254):651-653
[64] Crews CM, Alessandrini A, Erikson RL. The primary structure of MEK,a protein kinase that phosphorylate the ERK gene product[J]. Science, 1992,258 (5081):478-480
[65] Crews CM,Erikson RL Purification of a murine protein-tyrosine/threoninc kinase that phosphorylates and activates the Erk-1 gene product:relationship to the fission yeast byrl gene product[J].Proc.Natl. Acad.Sci.USA.1992,89(17):8205-8209
[66] Zheng CF, Guan KL.Properties of MEKs, the kinase that phosphorylate and activate the extracellular signal-regulated kinase[J]. J.Biol. Chem.1993,268(32):23933-23939
[67] Cantley LC, Auger KR, Carpenter C,et al. Oncogenes and signal transduction[J]. Cell.1991,64(2):281-302
[68] Gause KG, Homma MK, Licciardi KA,et al.Effects of phorbol ester on mitogen- activated protein kinase kinase activity in wild-type and phorbol ester-resistant EL4 thymoma cells[J]. J. Biol.Chem.1993,268(22):16124-16129
[69] Lev S, Moreno H, Martinez R,et al. Protein tyrosine kinase PYK2 involved in Ca(2+)- induced regulation of ion channel and MAP kinase functions [J] .Nature, 1995,376(6543):737-745
[70] Delia Rocca GJ ,Van Biesen T, Daaka Y ,et al.Ras-dependent mitogen-activated protein kinase activation by G protein- coupled receptors-convergence of kinase of Gi- and Gq-mediated pathways on calcium/calmodulin,Pyk2, and Src kinase[J].J.Biol.Chem. 1997,272(31): 19125-19132
[71] Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades[J].J.Biol.Chem. 1998,273(4): 1839-1842
[72] Roberson Ed, English JD, Adams JP,et al. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus [J]. J. Neurosci. 1999,19(11):4337-4348
[73] Sun H, Charles CH, Lau LE, Tonks NK.MKP-l(3CH134),an immediate early gene product,is a dual specificiy phosphatase that dephosphorylaaes MAP kinase in vivo[J]. Cell 1993,75(3):487-493
[74] Ward Y, gupta S, Jensen P,et al. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1[J]. Nature 1994,367(6464):651-654
[75] Chu Y, Solski PA, Khosravi-Far R,et al.The mitogen- activated protein kinase phosphatases PAC1,MKP-1 and MPK-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation[J].J.Biol.Chem.1996,271(11):6497-6501
[76] Muda M,Theodosiou A,Rodrigues N,et al.The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases[J].J Biol.Chem.l996,271(44):27205-27208
[77] Boulton T G,Nye S H, Robbins D J,et al. ERKs: a family of protein-serine/ threonine kinase that are activated and tyrosine phosphorylated in response to insulin and NGF[J]. Cell 1991,65(4):663-675
[78] Fiore RS, Bayer VE, Pelech SL, Cooper JA, Baraban JM. P42 mitogen-activated protein kinase in brain:prominent localization in neuronal cell bodies and dendrites[J].Neuroscience 1993,55(2):463-472
[79] Flood DG, Finn JP, Walton KM,et al.Immunolocalization of the mitogen- activated protein kinases P42 MAPK and JNK 1,and their regulatory kinases MEK1 and MEK 4,in adult rat central nervous system[J].J.Comp.Neurol. 1998,398(3):373-392
[80] Ortiz J, Harris HW,Guitart X,et al. Extracellular signal-regulated protein kinases (ERKs) and ERX kinase(MEK) in brain:regional distribution and regulation by chronic morphine[J].J.Neurosci. 1995,15(2): 1285-1297
[81] Brott BK, Alessandrini A, Largaespada DA,et al. MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues[J].Cell Growrth Differ,1993,4(11):921-929
[82] Dwivedi Y, Rizavi HS, Roberts RC,et al.Reduced activation and expression of ERK1/2 kinase in the post-mortem brain of depressed suicide subjects[J]. J Neurochem, 2001,77(3):916-928
[2] Erin E. Rodgers and Anne B. Theibert. Functions of PI 3-kinase in development of the nervous system[J].International Journal of Development Neuroscience, 2002,20(3-5): 187-197
[3] F.H. Gage. Mammalian neural stem cells[J].Science ,2000,287(5457): 1433-1438.
[4] S. Goldman.Stem and progenitor cell-based therapy of the human central nervous system[J].Nat. Biotechnol. 2005, 23 (7) 862-871.
[5]Downward J.Signal transduction:Regulating S6 kinase.[J].Nature, 1994;371(6496): 378-379.
[6] Sirén AL Ehrenreich H.Erythropoietin a novel concept for neuroprotection[J]. Eur Arch Psychiatry Clin Neurosci,2001,251 (4): 179-184
[7] Timothy G. Cross, Dagmar Scheel-Toellner,et al. Serine/Threonine Protein Kinases and Apoptosis[J]. Experimental Cell Research,2000,256(1):34-41
[1]Schaeffer HJ,Weber MJ.Mitogen-activated protein kinases:specific messages from ubiquitous messengers[J].Mol.Cell.Biol.1999(4) 19:2435-2444
[2]Philippe Lenormand,Jean-Marc Brondello,Anne Brunet,et al.Growth Factor-induced p42/p44 MAPK Nuclear Translocation and Retention Requires Both MAPK Activation and Neosynthesis of Nuclear Anchoring Proteins[J].Cell Biol.1998,142(3):625-633
[3]Huang EJ,Reichardt LF.Neurotrophins:roles in neuronal development and function.[J].Annu Rev Neurosci,2001,24:677-736.
[4]Marinissen MJ,Gutkind JS.G-protein-coupled receptors and signaling networks:emerging paradigms[J].Trends Pharmacol Sci,2001,22(7):368-376.
[5]Dawson TM,Ginty DD.CREB family transcription factors inhibit neuronal suicide [J].Nat Med.2002,8(5):450-451.
[6]Weeber EJ,Sweatt JD.Molecular neurobiology of human cognition[J].Neuron 2002,33(6):845-848.
[7]F.H.Gage.Mammalian neural stem cells[J].Science,2000,287(5457):1433-1438.
[8]S.Goldman.Stem and progenitor cell-based therapy of the human central nervous system[J].Nat.Biotechnol.2005,23(7):862-871.
[1]杨德森.行为医学[M].湖南科学技术出版社.1999,400.
[2]Czeh B,Michaelis T,Watanabe T,et al.Stress-induced changes in cerebral metabolites,hippocampal volume,and cell proliferation are prevented by antidepressant treatment with tianeptine[J].Proc Natl Acad Sci USA,2001,98(22):12796-12801.
[3]Fossati P,Radtchenko A,Boyer P.Neuroplasticity:from MRI to depressive symptoms[J].Eur Neuropsychopharmacol,2004,14Supp 15:S503-510
[4]Sheline Y,Wang P,Gado M,et al.Hippocampal atrophy in recurrent major depression[J].Proc Natl Acad Sci USA,1996,93(9):3908-3913.
[5]Malberg JE,Eisch AJ,Nestler EJ,et al.Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus[J].The Journal of Neuroscience Neurosci 2000,20(24):9104-9110.
[6]Malberg JE,Schechter LE.Increasing hippocampal neurogenesis:a novel mechanism for antidepressant drugs[J].Currrnt Pharmaceutical Design,2005,11(2):145-155
[7]张黎明,李云峰,宫泽辉.神经元再生:抑郁症治疗的新策略[J].生理科学进展2005,36,(2):109-112.
[8] L Santarelli, M Saxe, C Gross,et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants[J].Science, 2003,301 (5634):805-809.
[9] Bunney W E and Davis J M.Norepinephrine in depressive reactions. A review Arch [J].Gern.Psychiatry, 1965,13(6):483-494.
[10] A Cipriani, P Brambilla, T Furukawa,et al. Fluoxetine versus other types of pharmacotherapy for depression[J].Cochrane Database Syst. Rev.2005,19(4)CD004185.
[11] H J Lee, J W Kim, S V Yim, et al.Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats.[J] Mol.Psychiatry 2001,6(6)610,725-728.
[12] Leevers, S. J., Vanhaesebroeck, B., and Waterfield, M. D. Signalling through phosphoinositide 3-kinases: the lipids take centre stage[J]. Curr.Opin. Cell Biol. 1999,11(2), 219-225
[13] Brunet, A, Datta, S R, and Greenberg, M E.Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway[J]. Curr. Opin. Neurobiol. 2001,11(3), 297-305
[14] Hawkins, P T, Anderson, K E, Davidson, K, and Stephens, L R. Signalling through Class I PI3Ks in mammalian cells[J].Biochem. Soc. Trans. 2006,34 (Pt5), 647-662
[15] Hsiung SC, Adlersberg M, Arango V,et al.Attenuated 5-HT1A receptor signaling in brains of suicide victims: Involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase[J]. J Neurochem 2003,87(1): 182-194.
[16] Karege F, Perroud N, Burkhardt S,et al.Alteration in kinase activity but not in protein levels of protein kinaseB and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims[J]. Biol Psychiatry 2007,61(2): 240-245.
[17] Krishnan V, Han M H, Mazei-Robison M, et al.AKT Signaling within the Ventral Tegmental Area Regulates Cellular and Behavioral Responses to Stressful Stimuli [J].Biol Psychiatry. 2008,64(8):691-700.
[18] Einat H, Yuan P, Gould TD,et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation[J].J Neurosci. 2003;23(19): 7311-7316.
[19] Mercier G, Lennon AM, Renouf B, et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes[J]. J Mol Neurosci. 2004;24(2):207-216.
[20] Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor-and cytokine-induced alterations of neuroplasticity[J]. Neuroscience. 2005;135(3):659-678.
[21] Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS.A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment[J]. Biol Psychiatry. 2007;61(5):661-670.
[22] Sanna, P P , Cammalleri, M, Berton, F,et al. Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region[J]. J.Neurosci. 2002,22(9), 3359-3365
[23] H Manev, T Uz, N R Smalheiser, R Manev.Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro[J].Eur. J. Pharmacol. 2001 411 (1-2):67-70
[24] BL Jacobs, H Praag, F H Gage.Adult brain neurogenesis and psychiatry: a novel theory of depression [J]. Mol. Psychiatry 2000,5 (3):262-269.
[25] SC Wright, J Zhong, J W Larrick.Inhibition of apoptosis as a mechanism of tumor promotion[J].FASEB J. 1994,8 (9):654-660.
[26] D Peer, Y Dekel, D Melikhov, R Margalit.Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models[J].Cancer Res. 200,464 (20):7562-7569.
[27] R Manev, T Uz, H Manev.Fluoxetine increases the content of neurotrophic protein S100 beta in the rat hippocampus[J].Eur. J.Pharmacol. 2001,420(2-3): R1-R2.
[28] M E Maragnoli, F Fumagalli, M Gennarelli, G Racagni, M A Riva.Fluoxetine and olanzanpine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain[J]. Biol. Psychiatry 2004,55 (11): 1095 - 1102.
[29] E Nahon, A. Israelson, S Abu-Hamad, S B Varda.Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death[J]. FEBS Lett. 2005,579(22):5105-5110.
[30] Y F Li, Y Z Zhang, YQ Liu,et al.Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice[J]. Acta Pharmacol. Sin. 2004,25(11): 1408-1412.
[31] Datta SR,Brunet A,Greenberg M E.Cellular survival:a play in three Akts[J]. Genes Dev, 1999,3(22) :2905-2927
[32] Downward, J. Mechanisms and consequences of activation of protein kinase B/Akt[J]. Curr Opin Cell Biol. 1998,10(2).262-267
[33] Alessi, D R, James, S R, Sownes, C P,et al.Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha [J]. Curr. Biol. 1997,7(4):261-269
[34] Andjelkovic, M, Maira, S M, Cron, P,et al. Domain Swapping Used To Investigate the Mechanism of Protein Kinase B Regulation by 3-Phosphoinositide-Dependent Protein Kinase 1 and Ser473 Kinase[J].Molecular and Cellular Biology Mol. Cell. Biol. 1999,19(7):5061-5072
[35] Yano S, Tokumitsu H, Soderling T R.Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway[J].Nature,1998; 396(6711):584-587
[36] del Peso, L, Gonzalez-Garcia, M, Page, C,et al.Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt[J]. Science, 1997, 278 (5338):687-689
[37] Datta, S R, Dudek, H, Tao, X,et al.Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery[J].Cell ,1997, 91(2):231-241
[38] Cardone, M H, Roy, N, Stennicke, H R, et al.Regulation of Cell Death Protease Caspase-9 by Phosphorylation [J].Science,1998, 282(5392): 1318-1321
[39] Cross, D A E, Alessi, D R, Cohen, P,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B[J].Nature 1995,378,785-789
[40] Pop M and Cooper GM.Role of glycogen synthase kinase 3 in the phosphadylinositol 3 kinase/Akt cell survival pathway[J]J Biol Chem, 1998,273(32): 19929-19932
[41] Kennedy SG,Kandel ES,Cross TK,et al.Akt/protein kinase B inhibits cell death by preventing the release cytochrome C from mitochondria[J]. Molecular and Cellular Biology, Mol Cell Biol, 1999,19(8):S800-S810.
[42] Brunet A,BonniA,Zigmond MJ,et al.Akt promotes cell survival by phosphorylating and inhibiting a Forkead transcription factor[J].Cell,1999,96(3):857-868.
[43] Frebel, K, and Wiese, S. Signalling molecules essential for neuronal survival and differentiation[J]. Biochem. Soc. Trans. 2006,34(Pt6):1287-1290
[44] Kelly, A, and Lynch, M A. Long-term potentiation in dentate gyrus of the rat is inhibited by the phosphoinositide 3-kinase inhibitor, wortmannin[J]. Neuropharmacology ,2000,39 (4):643-651
[45] Raymond, C R, Redman, S J, and Crouch, M F. The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons[J]. Neuroscience 2002,109(3):531-536
[46] Barros, D M, Mello e Souza, T, de Souza, M M, et al.LY294002, an inhibitor of phosphoinositide 3-kinase given into rat hippocampus impairs acquisition, consolidation and retrieval of memory for one-trial step-down inhibitory avoidance[J]. Behav. Pharmacol. 2001,12(8):629-634
[47] Mizuno, M, Yamada, K, Takei, N, et al.Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation[J]. Mol. Psychiatry 2003, 8(2):217-224
[48] Horwood, J M, Dufour, F, Laroche, S, and Davis, S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat[J]. Eur. J. Neurosci. 2006,23 (12):3375-3384
[49] Lin, C H, Yeh, S H, Lin, C H,et al. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala [J].Neuron 2001,31(5):841-851
[50] Chen, X, Garelick, M G., Wang, H,et al.PI3 kinase signaling is required for retrieval and extinction of contextual memory [J].Nat. Neurosci. 2005,8(7):925- 931
[51] Man, H Y, Wang, Q, Lu, W Y,et al.Wymann,M P, MacDonald, J F, and Wang, Y T. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons[J]. Neuron 2003,38(4):611-624
[52] Perkinton, M S, Ip, J K, Wood, G. L,et al. Phosphatidylinositol 3-kinase is a central mediator of NMD A receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones[J]. J. Neurochem. 2002,80(2):239-254
[53] Cammalleri, M, Lutjens, R, Berton, F, et al.Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1[J]. Proc. Natl. Acad. Sci. U. S. A. 2003,100(24): 14368-14373
[54] Schaeffer HJ,Weber MJ.Mitogen-activated protein kinases: specific messages from ubiquitous messengers[J].Mol.Cell. Biol.l999,19(4):2435-2444
[55] Philippe Lenormand, Jean-Marc Brondello, Anne Brunet, et al. Growth Factor-induced p42/p44 MAPK Nuclear Translocation and Retention Requires Both MAPK Activation and Neosynthesis of Nuclear Anchoring Proteins[J]. Cell Biol. 1998 August 10; 142(3):625-633
[56] Houslay MD, Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling[J]. Mol. Pharmacol. 2000,58(4):659-668
[57] Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function[J].Annu Rev Neurosci ,2001,24:677-736.
[58] Marinissen MJ, Gutkind JS.G-protein-coupled receptors and signaling networks: emerging paradigms[J].Trends Pharmacol Sci ,2001,22(7):368-376.
[59] Dawson TM, Ginty DD.CREB family transcription factors inhibit neuronal suicide[J]. Nat Med .2002,8(5):450-451.
[60] Weeber EJ,Sweatt JD.Molecular neurobiology of human cognition[J].Neuron 2002,33(6):845-848.
[61] Frodin M, Gammeltoft S.Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction [J] .Mol Cell Endocrinol 1999,151(1-2):65-77.
[62] Karin M.The regulation of AP-1 activity by mitogen-activated protein kinases[J]. Philos Trans R Soc Lond B Biol Sci, 1996,351(1336): 127-134.
[63] Garrington, T P, Johnson G L.Organization and regulation of mitogen-activated protein kinase signaling pathways[J].Curr Opin Cell Biol. 1999,11 (2):211-218.
[64] Brunet A D,Roux P, Lenormand S,et al.Nuclear translocation of p42/p44 mitogen- activated protein kinase is required for growth factor-induced gene expression and cell cycle entry [J].EMBO J. 1999,18(3):664-674.
[65] Pages G, P Lenormand, G. L'Allemain,et al.Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation[J]. Proc Natl Acad Sci USA.1993,90(18):8319-8323
[66] Buckley S, B Driscoll, L Barsky,et al. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2 [J]. Am J Physiol 1999,277(1pt 1):L159-L166.
[67] Xia Z, Dickens M,Raingeaud J,et al. Opposing effects of ERK and JNK-p38 MAPKs on apoptosis[J]. Science 1995,270(5240): 1326-1331.
[68] Shakibaei M, Schulze-Tanzil G, de Souza P,et al.Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes[J].J.Biol.Chem. 2001,276(16): 13289-13294.
[69] Boucher M J, Morisset J, Vachon P H, Reed J C, Laine J, and Rivard N MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells[J].J Cell Biochem. 2000, 79 (3):355-369
[70] Desire L,Courtois Y, and Jeanny J C.Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal neuronal bcl-xL and bcl-2 expression through a fibroblast growth factor receptor 1- and ERK-dependent pathway [J]. J Neurochem. 2000,75(1):151-163
[71] Choi IJ, Kim JS, Kim JM, Jung HC, Song IS. Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells [J].Infect Immun. 2003,71(2):830-837.
[72] Zimmermann, S, and Moelling, K. Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)[J].Science 1999,286(5445):1741-1744
[73] Chen, D, Heath, V, O'Garra, A, Johnston, J, and McMahon, M. Sustained Activation of the Raf-MEK-ERK Pathway Elicits Cytokine Unresponsiveness in T Cells[J].The Journal of Immunology (J. Immunol).1999,163(11):5796-5805
[74] Sanchez-Margalet, V, Goldfine, I D, Vlahos, C J, and Sung, C K. Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002[J]. Biochem. Biophys. Res. Commun 1994,204(2):446-452
[75] Karin Moelling, Karen Schad, Magnus Bosse, et al.Regulation of Raf-Akt Cross-talk [J]. The journal of biological chemistry 2002,277(34):31099-31106
[1]Czeh B,Michaelis T,Watanabe T,et al.Stress-induced changes in cerebral metabolites,hippocampal volume,and cell proliferation are prevented by antidepressant treatment with tianeptine[J].Proc Natl Acad Sci USA,2001,98(22):12796-12801.
[2]Fossati P,Radtchenko A,Boyer P.Neuroplasticity:from MRI to depressive symptoms [J].Eur Neuropsychopharmacol,2004,14Supp 15:S503-510
[3]Sheline Y,Wang P,Gado M,et al.Hippocampal atrophy in recurrent major depression[J].Proc Natl Acad Sci USA,1996,93(9):3908-3913.
[4]Malberg JE,Eisch AJ,Nestler EJ,et al.Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus[J].The Journal of Neuroscience Neurosci 2000,20(24):9104-9110.
[5]Malberg JE,Schechter LE.Increasing hippocampal neurogenesis:a novel mechanism for antidepressant drugs[J].Currrnt Pharmaceutical Design,2005,11(2):145-155
[6]张黎明,李云峰,宫泽辉.神经元再生:抑郁症治疗的新策略[J].生理科学进展2005,36,(2):109-112.
[7]L Santarelli,M Saxe,C Gross,et al.Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants[J].Science 2003,301(5634):805-809.
[8]Bunney W E and Davis J M.Norepinephrine in depressive reactions.A review[J].Arch.Gen.Psychiatry 1965,13(6):483-494.
[9]A Cipriani,P Brambilla,T Furukawa,et al.Fluoxetine versus other types of pharmacotherapy for depression[J].Cochrane Database Syst.Rev.2005,19(4)CD004185.
[10]H J Lee,J W Kim,S V Yim,et al.Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats[J].Mol.Psychiatry 2001,6(6) 610,725-728.
[11]Huang,E J,Reichardt,L F.TRK receptors:roles in neuronal signal transduction[J].Annu.Rev.Biochem.2003,72,609-642.
[12]Einat,H,Manji,H K.Cellular plasticity cascades:genes-to-behavior pathways in animal models of bipolar disorder[J].Biol.Psychiatry 2006,59(12),1160-1171
[13]Coyle,J T,Duman,R S.Finding the intracellular signaling pathways affected by mood disorder treatments[J].Neuron 2003,38(2),157-160
[14]Manji,H K,Duman,R S.Impairments of neuroplasticity and cellular resilience in severe mood disorders:implications for the development of novel therapeutics[J].Psychopharmacol.Bull.2001,35(2):5-49.
[15]Kazanis,I,Giannakopoulou,M,Philippidis,H,Stylianopoulou,F.Alterations in IGF-I,BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration[J].Exp.Neurol.2004,186(2):221-234
[16] Schabitz,W R, Sommer, C, Zoder,W,et al.Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia[J]. Stroke 2000,31 (9):2212-2217
[17] Zhang, Y, Pardridge, W M.Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brainderived neurotrophic factor conjugated to a blood-brain barrier drug targeting system[J]. Stroke 2001,32(6): 1378-1384
[18] Larsson, E, Nanobashvili, A, Kokaia, Z, Lindvall, O.Evidence for neuroprotective effects of endogenous brain derived neurotrophic factor after global forebrain ischemia in rats[J]. J. Cereb. Blood Flow Metab. 1999,19(11), 1220-1228.
[19] Kokaia, Z, Nawa, H, Uchino, H,et al.Regional brain derived neurotrophic factor mRNA and protein levels following transient forebrain ischemia in the rat[J]. Brain Res. Mol. Brain Res. 1996,38(1):139-144.
[20] Xu, H, Chen, Z, He, J,et al.Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus[J]. Hippocampus 2006,16(6):551-559.
[21] Hayley, S, Poulter, M O, Merali, Z, Anisman, H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity[J]. Neuroscience 2005,135(3),659-678.
[22] Manji, H K, Chen, G. PKC, MAP kinases and the Bcl-2 family of proteins as long-term targets for mood stabilizers[J].Mol.Psychiatry 2002,7(Suppl 1):S46-S56.
[23] Shirayama, Y, Chen, A C, Nakagawa, S,et al. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression[J]. J. Neurosci. 2002,22(8):3251-3261.
[24] Einat, H, Yuan, P, Gould, T D,et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation[J]. J. Neurosci. 2003,23(19):7311-7316.
[25] Mercier, G, Lennon, A M, Renouf, B,et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes[J].J. Mol. Neurosci. 2004,24(2):207-216.
[26] Hayley, S, Poulter, M O, Merali, Z, Anisman, H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity[J]. Neuroscience 2005,135(3):659-678.
[27] Manji, H K, Moore, G J, Chen, G.Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness[J]. J. Clin. Psychiatry 2000,61 Suppl 9,82-96.
[28] Kuipers, S D, Bramham, C R.Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy[J]. Curr. Opin. Drug Discov.Devel. 2006,9(5):580-586.
[29] Siuciak, J A, Lewis, D R, Wiegand, S J, Lindsay, R M.Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)[J]. Pharmacol. Biochem. Behav. 1997, 56(1):131-137.
[30] Einat, H, Manji, H K. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder[J]. Biol.Psychiatry2006,59(12): 1160-1171.
[31] Chen, G., Manji, H K.The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers[J]. Curr. Opin. Psychiatry 2006, 19(3):313-323.
[32] Kalueff, A V, Avgustinovich, D F, Kudryavtseva, N N, Murphy, D L. BDNF in anxiety and depression[J]. Science 2006,312(5780):1598-1599.
[33] Einat H, Yuan P, Gould TD, et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation[J]. J Neurosci. 2003;23(19):7311 -7316.
[34] Airaksinen MS, Saarma M.The GDNF family: signaling, biological functions and therapeutic value[J]. Nat Rev Neurosci 2002,3(5):383-394
[35] Ducray A, Krebs SH, Schaller B,et al.GDNF-family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon[J] .Brain Res 2006,1069(1): 104-112
[36] Lin LF, Doherty DH, Lile JD,et al.GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons[J].Science 1993,260(5111): 1130-1132
[37] Sarabi A, Hoffer BJ, Olson L, Morales M. GFR alpha-1 is expressed in parvalbumin GABAergic neurons in the hippocampus[J]. Brain Res 2000,877(2): 262-670
[38] Cheng H, Fu YS, Guo JW. Ability of GDNF to diminish free radical production leads to protection against kainite-induced excitotoxicity in hippocampus[J]. Hippocampus 2004,14(1):77-86.
[39] Gratacos E, Pe'rez-Navarro E, Tolosa E, Arenas E, Alberch J. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members[J]. J Neurochem 2001,78(6):1287-1296.
[40] Quintero EM, Willis LM, Zaman V, et al.Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway[J].Neuroscience 2004,124(1): 137-146
[41] Pe'rez-Navarro E, Akerud P, Marco S, et al. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease[J]. Neuroscience 2000,98(1):89-96
[42] Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders[J]. Proc Natl Acad Sci USA 1998,95(2): 13290-13295.
[43] Frodl T, Meisenzahl EM, Zetzsche T, et al.Hippocampal changes in patients with a first episode of major depression[J].Am J Psychiatry 2002,159(7): 1112-1128.
[44] Rajkowska G. Post-mortem studies in mood disorders indicate altered numbers of neurons and glial cells[J]. Biol Psychiatry 2000,48(8):766-777
[45] Strelau J, Unsicker K. GDNF family members and their receptors:expression and functions in two oligodendroglial cell lines representing distinct stages of oligodendroglial development[J]. Glia 1999,26(4):291-301
[46] Tomac AC, Agulnick AD, Haughey N, et al. Effects of cerebral ischemia in mice deficient in Persephin[J]. Proc Natl Acad Sci U S A2002,99(14):9521-9526.
[47] Kitagawa H, Sasaki C, Zhang WR,et al.Induction of glial cell line-derived neurotrophic factor receptor proteins in cerebral cortex and striatum after permanent middle cerebral artery occlusion in rats[J]. Brain Res 1999,834(1-2):190-195
[48] Kokaia Z, Airaksinen MS, Nanobashvili A, et al. GDNF family ligands and receptors are differentially regulated after brain insults in the rat[J]. Eur J Neurosci 1999,11(4): 1202-1216
[49] Miyazaki H, Okuma Y, Fujii Y,et al.Glial cell line-derived neurotrophic factor protects against delayed neuronal death after transient forebrain ischemia in rats[J]. Neuroscience 1999,89(3):643-647
[50] Miyazaki H, Nagashima K, Okuma Y, Nomura Y. Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats[J]. Brain Res 2001,922(2): 165-172.
[51] Rosenblad C, Kirik D, Devaux B,et al.Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle[J]. Eur J Neurosci 1999,11(5): 1554-1566
[52] Rosenblad C, Kirik D, Bjo¨rklund A. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model[J]. Exp Neurol 2000,161(2):503-516
[53] Rossi J, Luukko K, Poteriaev D, et al. Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR2, a functional neuroturin receptor[J].Neuron 1999,22(2):243-252
[54] Stromberg I, Bjorklund L, Johansson M, et al. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo[J]. Exp Neurol 1993,124(2):401 -412
[55] Tseng JL, Bruhn SL, Zurn AD, Aebischer P. Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy[J]. Neuroreport 1998,9(8): 1817-1822
[56] Takebayashi M, Hisaoka K, Nishida A, et al. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorder[J]. Int J Neuropsychopharmacol 2006,9(5):607-612.
[57] Rosa AR, Frey BN, Andreazza AC, et al. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder[J]. Neurosci Lett 2006,407(2): 146-150
[58] Chen ACH, Eisch AJ, Sakai N,et al.Regulation of GFR a-1 and a-2 mRNAs in rat brain by electroconvulsive seizure[J]. Synapse 2001,39(1):42-50
[59] Hisaoka K, Nishida A, Koda T, et al.Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioma cells[J]. J Neurochem 2001;79(1):25-34.
[60] Hisaoka K, Takebayashi-M, Tsuchioka M,et al. Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells[J]. J Pharmacol Exper Therap 2007,321(1): 148-157.
[61] Hisaoka K, Maeda N, Tsuchioka M, Takebayashi M. Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production[J]. Brain Res 2008,1196:53-58.
[62] Mercier G, Lennon AM, Renouf B, et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes[J]. J Mol Neurosci 2004,24(2):207-216.
[63]Michel T M, Frangou S, Camara S,et al.Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: A comparative post-mortem study[J].Eur Psychiatry 2008,23(6):413-420.
[64] Banner LR, Patterson PH.Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia[J]. Proc Natl Acad Sci USA1994, 91(15):7109-7113.
[65] Banner LR, Moayeri NN, PattersonPH. Leukemia inhibitory factor is expressed in astrocytes following cortical brain injury[J]. Exp Neurol 1997,147(1): 1-9.
[66] Jankowsky JL, Patterson PH.Differential regulation of cytokine expression following pilocarpine-induced seizure[J]. Exp Neurol 1999,159(2):333-346
[67] Suzuki S, Tanaka K, Nogawa S, et al.Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats[J]. J Cereb Blood Flow Metab 2000,20(4):661- 668.
[68] Minami M, Maekawa K, Yamakuni H, et al.Kainic acid induces leukemia inhibitory factor mRNA expression in the rat brain: differences in the time course of mRNA expression between the dentate gyrus and hippocampal CA1/CA3 subfields[J]. Brain Res Mol Brain Res 2002,107(1):39-46.
[69] Bauer S, Rasika S, Han J,et al.Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium[J]. J Neurosci 2003,23(5): 1792-1803
[70] Sriram K, Benkovic SA, Hebert MA,et al. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the l-methyl-4- phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?[J]. J BiolChem2004,279(19): 19936-19947.
[71] Rao MS, Sun Y, Escary JL, et al.Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons[J].Neuron 1993,11(6): 1175-1185.
[72] Corness J, Shi TJ, Xu ZQ, Brulet P, Hokfelt T.Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy[J]. Exp Brain Res 1996,112(1):79-88.
[73]Sun Y, Zigmond RE.Leukaemia inhibitory factor induced in the sciatic nerve after axotomy is involved in the induction of galanin in sensory neurons[J].Eur J Neurosci 1996,8(10):2213-2220.
[74] Holmberg KH, Patterson PH.Leukemia inhibitory factor is a key regulator of astrocytic, microglial and neuronal responses in a low-dose pilocarpine injury model[J]. Brain Res 2006,1075(l):26 -35.
[75]Sugiura S, Lahav R, Han J,et al.Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro[J]. Eur J Neurosci 2000, 12(2):457-466.
[76]Kerr BJ, Patterson PHPotent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse[J]. Exp Neurol 2004,188(2):391-407.
[77]Kerr BJ, Patterson PH.Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury[J]. Glia 2005,51(1):73-79.
[78] Bauer S, Patterson PH.The cell cycle-apoptosis connection revisited in the adult brain[J]. J Cell Biol 2005,171(4):641- 650.
[79] Bonni A, Sun Y, Nadal-Vicens M,et al.Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway[J].Science 1997,27(5337)8:477-483.
[80] Molne M, Studer L, Tabar V,et al.Early cortical precursors do not undergo LIF-mediated astrocytic differentiation[J].J Neurosci Res 2000,59(3):301-311.
[81] Viti J, Feathers A, Phillips J, Lillien L.Epidermal growth factor receptors control competence to interpret leukemia inhibitory factor as an astrocyte inducer in developing cortex[J]. J Neurosci 2003,23(8):3385-3393
[82] Chang MY, Park CH, Son H, Lee YS, Lee SH.Developmental stage dependent self-regulation of embryonic cortical precursor cell survival and differentiation by leukemia inhibitory factor[J]. Cell Death Differ 2004,11(9):985-996.
[83]Barnabe-Heider F, Wasylnka JA, Fernandes KJ,et al.Evidence that embryonic neurons regulate the onset of cortical gliogenesis via cardiotrophin-1 [J].Neuron 2005,48(2):253-265.
[84] He F, Ge W, Martinowich K,et al.A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis[J].Nat Neurosci 2005,8(5):616-625.
[85] Williams RL, Hilton DJ, Pease S,et al.Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells[J].Nature 1988,336(6200):684-687.
[86]Wright LS, Li J, Caldwell MA,et al.Gene expression in human neural stem cells: effects of leukemia inhibitory factor[J]. J Neurochem 2003,86(1): 179 -195.
[87] Shimazaki T, Shingo T, Weiss S.The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells[J]. J Neurosci 2001,21(19):7642-7653.
[88] Pitman M, Emery B, Binder M,et al.LIF receptor signaling modulates neural stem cell renewal[J].Mol Cell Neurosci 2004,27(3):255-266.
[89] Bonaguidi M A, McGuire T, Hu M,et al.LIF and BMP signaling generate separate and discrete types of GFAP expressing cells[J]. Development 2005,132(24):5503-5514.
[90] Gregg C, Weiss S.CNTF/LIF/gp 130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain[J]. Development 2005,132(2):565-578
[91] Chojnacki A, Shimazaki T, Gregg C, Weinmaster G, Weiss S.Glycoprotein 130 signaling regulates Notch 1 expression and activation in the self-renewal of mammalian forebrain neural stem cells[J]. J Neurosci 2003,23(5):1730 -1741.
[92] Sylvian Bauer and Paul H. Patterson. Leukemia inhibitory factor promotes neural stem cell self-renewal in the adult brain[J]. J Neurosci (The Journal of Neuroscience), 2006 ,26(46): 12089 -12099
[93] Lemke R, Gadient R A, Schliebs R, Bigl V, Patterson P H .Neuronal expression of leukemia inhibitory factor (LIF) in the rat brain[J]. Neurosci Lett 1996,215(3): 205-208.
[94] Gadient R A, Lein P, Higgins D, Patterson P H. Effect of leukemia inhibitory factor (LIF) on the morphology and survival of cultured hippocampal neurons and glial cells[J]. Brain Res 1998,798(1-2):140-146.
[95] Auernhammer C J, Melmed S. Leukemia-inhibitory factor neuroimmune modulator of endocrine function[J]. Endocrine Rev 2000,21(3): 313-345.
[96] Pechnick R N,Chesnokova V M,Kariaqina A,et al. Reduced immobility in the forced swim test in mice with a targeted deletion of the leukemia inhibitory factor (LIF) gene[J].Neuropsychopharmacology. 2004,29(4):770-776.
[97]Herr I,Debatin K.Cellular stress response and apoptosisin cancer therapy[J].Blood, 2001,98(9):2603-2604.
[98] Desagher S,Osensand A,Nichols A,et al.Bidinduced conformational change of Bax is responsible fo rmitochondrial cytochrome C release during apoptosis[J].J Cell Biol,1999, 144(3):891-901.
[99] Gross A,Mcdonneu M J,Korsmeyer S J,et al.Bcl-2 family members and mitochondria in apoptosis[J].GenDev,1999,13(2): 1899-1911.
[100] Myers KM, Fiskum G, Liu Y, Simmens S J, Bredesen D E, Murphy A N. Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability[J]. J Neurochem 1995,65(6):2432-2440
[101] Manakova S, Puttonen KA, Raasmaja A, Mannisto P T. The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA -induced toxicity[J].Toxicol Lett 2004,154( 1-2): 117-123.
[102] Rolletschek A, Chang H, Guan K,et al.Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors[J]. Mech Dev2001,105(1-2): 93-104.
[103] Bachmann RF, Schloesser RJ, Gould TD, Manji HK.Mood stabilizerstarget cellular plasticity and resilience cascades: implications for the development of novel therapeutics[J]. Mol Neurobiol,2005,32(2): 173-202.
[104] Hayley S, Poulter MO, Merali Z, Anisman H.The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity[J]. Neuroscience 2005,135(3): 659-678.
[105] Arakawa, Y, Sendtner, M, Thoenen, H.Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines[J].J. Neurosci. 1990.10(11):3507-3515.
[106] Forger, N G, Roberts, S L, Wong, V, Breedlove, S M.Ciliary neurotrophic factor maintains motoneurons and their target muscles in developing rats[J]. J. Neurosci. 1993,13(11):4720-4726.
[107] Forger, N G, Wagner, C K, Contois, M,et al.Ciliary neurotrophic factor receptor alpha in spinal motoneurons is regulated by gonadal hormones[J]. J. Neurosci. 1998,18(21):8720-8729
[108] Masu, Y, Wolf, E, Holtmann, B,et al.Disruption of the CNTF gene results in motor neuron degeneration[J]. Nature 1993,365(6441):27-32.
[109] Takahashi, R, Yokoji, H, Misawa, H,et al.A null mutation in the human CNTF gene is not causally related to neurological diseases[J].Nat. Genet.l994,7(1):79-84.
[110] Gelernter, J, Van Dyck, C, van Kammen, DP, et al.Ciliary neurotrophic factor null allele frequencies in schizophrenia, affective disorders, and Alzheimer's disease[J].Am. J.Med.Genet. 1997,74(5):497-500.
[111] Gelernter, J, Kranzler, H, Lacobelle, J.Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF))[J].Genomics 1998,52(3):289-297.
[112] Orrell, RW, King, A W, Lane, R J,et al.Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis[J].J. Neurol. Sci. 1995, 132 (2): 126-128.
[113] Thome, J, Durany, N, Harsanyi, A, et al.A null mutation allele in the CNTF gene and schizophrenic psychoses[J]. NeuroReport 1996,7(8): 1413-1416.
[114] Thome, J, Kornhuber, J, Baumer, A,et al.Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases? [J].Neurosci. Lett. 1996,203(2): 109-110.
[115] Thome, J, Jonsson, E, Foley, P,et al.Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish population. Psychiatr[J].Genet.1997,7(2):79-82.
[116] Bloch, J, Bachoud-Levi, AC, Deglon N, et al. Neuroprotective Gene Therapy for Huntington's Disease,Using Polymer- Encapsulated Cells Engineered to Secrete Human Ciliary Neurotrophic Factor: Results of a Phase I Study[J]. Hum Gene Ther 2004,15(10):968-75.
[117] Grünblatt E, Hupp E, Bambula M,et al.Association study of BDNF and CNTF polymorphism to depression in non-demented subjects of the "VITA" study[J]. 2006,96(1-2):111-116.
[118] Barres B A, Hart I K, Coles H S,et al. Cell death and control of cell survival in the oligodendrocyte lineage[J]. Cell 1992,70(1):31-46.
[119] Barres B A, Schmid R, Sendnter M and Raff M C.Multiple extracellular signals are required for long-term oligodendrocyte survival[J].Development 1993,118 (1):283-295.
[120] Carson M J, Behringer R R, Brinster R L and McMorris-F A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice[J].Neuron 1993,10(4):729-740.
[121] Zumkeller W. The effect of insulin-like growth factors on brain myelination and their potential therapeutic application in myelination disorders[J]. Eur. J. Paediatr. Neurol.1997,1(4):91-101.
[122] Ye P, Lee K H and D'Ercole A J. Insulin-like growth factor-I(IGF-I) protects myelination from undernutritional insult: studies of transgenic mice overexpressing IGF-I in brain[J]. J. Neurosci. Res. 2000,62(5):700-708.
[123] Guan J, Bennet L, George S,et al.Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep[J]. J. Cereb. Blood Flow Metab. 2001,21(5):493-502.
[124] Lin S, Fan L W, Pang Y,et al. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat[J]. Brain Res. 2005,1063(1):15-26.
[125] Cao Y, Gunn A J, Bennet L,et al.Insulin-like growth factor (IGF)-l suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep[J]. J. Cereb.Blood Flow Metab. 2003, 23 (6):739-747.
[126] Mason J L, Xuan S, Dragatsis I, Efstratiadis A and Goldman J E. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination[J]. J. Neurosci. 2003,23(20):7710-7718.
[127] Yao D L, Liu X, Hudson L D and Webster H D. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis[J]. Proc. Natl Acad. Sci. USA 1995,92(13):6190-6194.
[128] Webster H D.Growth factors and myelin regeneration in multiple sclerosis[J].Mult. Scler. 1997,3(2): 113-120.
[129] Ye P and D'Ercole A J. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury[J].Endocrinology 1999,140(7):3063-3072.
[130] Ness J K and Wood T L. Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis[J]. Mol. Cell. Neurosci. 2002,20(3):476-488
[131] Cui Q L, Zheng W H, Quirion R and Almazan G Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival[J]. J. Biol. Chem. 2005,280(10): 8918-8928.
[132] McMorris F A, Smith T M, DeSalvo S and Furlanetto R W. Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development[J]. Proc. Natl Acad. Sci. USA 1986,83(3):822-826
[133] McMorris F A and Dubois-Dalcq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro[J]. J. Neurosci. Res. 1988,21(2-4): 199-209
[134] Masters B A,Werner H, Roberts C T Jr, LeRoith D and Raizada M K. Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains[J]. Regul. Pept. 1991,33(2): 117-131.
[135] Bhat N R, Hauser K F and Kindy M S. Cell proliferation and protooncogene induction in oligodendroglial progenitors[J]. J. Neurosci.Res. 1992,32(3):340-349.
[136] van der Pal R H, Koper J W, van Golde L M and Lopes-Cardozo M. Effects of cultures[J]. J. Neurosci. Res. 1988,19(4):483-490.
[137] Mozell R L and McMorris F A.Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures[J]. J. Neurosci.Res. 1991,30(2):382-390
[138] Yao D L, Liu X, Hudson L D and Webster H D. Insulin-like growth factor-I given subcutaneously reduces clinical deficits,decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis[J]. Life Sci 1996,58 (16): 1301-1306.
[139] Dubois-Dalcq M and Murray K.Why are growth factors important in oligodendrocyte physiology?[J]. Pathol. Biol. (Paris) 2000.48(1):80-86.
[140] Clemmons D R and Maile L A. Minireview: integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling[J]. Endocrinology 2003,144(5): 1664-1670.
[141] Dupont J, Pierre A, Froment P and Moreau C. The insulin-like growth factor axis in cell cycle progression[J]. Horm. Metab. Res. 2003,35(11-12):740-750.
[142] Khawaja X,Xu J, Liang J J, Barrett J E.Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: impliations for depressive disorders and future therapies[J]. J Neurosci Res 2004;75(4): 451-460.
[143] Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors[J]. Physiol Rev 1996;76(4):1005-1026.
[144] Anlar B, Sullivan KA, Feldman EL.Insulin-like growth factor-I and central nervous system development[J]. Horm Metab Res 1999;31 (2-3): 120-125.
[145] D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G The role of insulin like growth factors in the central nervous system[J]. Mol Neurobiol 1996;13(3):227- 255.
[146] Cohick W, Clemmons DR. The insulin-like growth factors[J]. Annu Rev Physiol 1993;55:131-153.
[147] Dumana C H,Schlesingera L,Terwilligera R,et al.Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise[J].Behzv Brain Res. 2009,198(2):366-71.
[1]杨德森.行为医学[M].湖南科学技术出版社.1999,400.
[2]李焕德,彭文兴.抑郁症药物治疗新进展[J].国外医学,精神病学分册,1997,24(3):129-133.
[3]Bunney W.E and Davis J.M.Norepinephrine in depressive reactions.A review.Arch[J].Gen.Psychiatry 1965,13(6):483-494.
[4]Sehildkraut J J.The catecholamine hypothesis of affective disorders.A review of supportive evidence[J].Int.J.Psychiatry 1967,4(3):203-217.
[5]Czeh B,Michaelis T,Watanabe T,et al.Stress-induced changes in cerebral metabolites,hippocampal volume,and cell proliferation are prevented by antidepressant treatment with tianeptine[J].Proc Natl Acad Sci USA,2001,98(22):12796-12801.
[6]Fossati P,Radtchenko A,Boyer P.Neuroplasticity:from MRI to depressive symptoms [J].Eur Neuropsychopharmacol,2004,14Suppl 5:S503-510
[7]Sheline Y,Wang P,Gado M,et al.Hippocampal atrophy in recurrent major depression[J].Proc Natl Acad Sci USA,1996,93(9):3908-3913.
[8]Yvette I,Sheline,Milan S,et al.Depression duration but not age predicts hippocampal volume loss in medically healthy woman with recurrent major depression[J].Neurosci,1999,19(12):5034-5043.
[9]Duman RS,Malberg J,Nakagawa S,et al.Neuronal plasticity and survival in mood disorders[J].Biol Psychiatry,2000,48(8):732-739.
[10]Duman RS,Malberg JE,Nakagawa S,et al.Regulation of adult neurogenesis by psychotropic drugs and stress[J].Pharmacol Exp Ther 2001,299(2):401-407.
[11]Benninghoff J Schmitt A,Mossner R,et al.When cells become depressed focus on neural stem cells in novel treatment strategies against depression[J].J Neural Transm,2002,109(5-6):947-962.
[12]Kempeman G.Regulation of adult hippocampal neurogenes implication for novel theories of major depression[J].Bipolar Disord,2002,4(1):17-23
[13]Malberg JE,Eisch AJ,Nestler EJ,et al.Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus[J].J Neurosci 2000,20(24):9104-9110.
[14]Malberg JE,Schechter LE.Increasing hippocampal neurogenesis:a novel mechanism for antisepressant drugs[J].Currrnt Pharmaceutical Design,2005,11(2):145-155
[15]朱兴族,罗质璞.抑郁症发病机制及治疗药物.神经药理学新论.[M]北京:人民卫生出版社,第一版,2004:1-20.
[16]张黎明,李云峰,宫泽辉.神经元再生:抑郁症治疗的新策略[J].生理科学进展,2005,36(2):109-112.
[17]Luca Santarelli,Michael Saxe,Cornelius Gross,et al.Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants[J].Science 2003.301(5634):805-809
[18]Duman RS,Nakagawa S,Malberg J.Regulation of adult neurogenesis by antidepressant treatment[J].Neuropsychopharmacology 2001,25(6):836-844.
[19]Gould E,Tanapat P,Rydel T,Hastings N.Regulation of hippocampal neurogenesis in adulthood[J].Biol Psychiatry 2000,48(8):715-720.
[20]Shors TJ,Miesegaes G,Beylin A,Zhao M,Rydel T,Gould E.Neurogenesis in the adult is involved in the formation of trace memories[J].Nature 2001,410(6826):372-376.
[21]Czeh B,Michaelis T,Watanabe T et al.Stress-induced changes in cerebral metabolites,hippocampal volume,and cell proliferation are prevented by antidepressant treatment with tianeptine[J].Proc Natl Acad Sci USA 2001,98(22):12796-12801.
[22]Palmer T,Takahashi J,Gage FH.The adult rat hippocampus contains primordial neural stem cells[J].Mol Cellular Neuroscience 1997,8(6):389-404.
[23]Gould E,Reeves AJ,Graziano MSA,Gross CG.Neurogenesis in the neocortex of adult primates[J].Science 1999,286(5439):548-552.
[24]Gould E,Vail N,Wagers M,Gross CG.Adult generated hippocampal and neocortical neurons in macaques have a transient existence[J].Proc Natl Acad Sci USA 2001;98(19):10910-10917.
[25]李云峰,刘艳芹,张有志等.抗抑郁剂对慢性应激小鼠海马神经元再生的影响[J].中国药理学通报,2004,20:385-388.
[26]Hellsten J,Wennstrom M,Mohapel P,Ekdahl CT et al.Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment[J].Eur J Neurosci,2002,16(2):283-290
[1]Ahmed S,Reynold BA,Weiss S.BDNF enhances the differentiation but not the survival of CNS stem cell-derived neuronal precursors[J].J Neurosci.1995,15(8):5765-5778
[2]Shetty AS,Turner DA.In vitro survival and differentiaton of neurons derived from epidenmal growth factor-responsive postnatal hippocampal stem cells:including effects of brain derived neurotrophic factor[J].J.Neurobiol.1998,35(4):395-425.
[3]Goldman SA,Luskin MB.Strategies utilized by migration neurons of the postnatal vertebrate forebrain[J].J.Trends Neurosci.1998,21(3):107-114
[4]Smith MA,Makina S,Kvetnansky R,et al.Stress and glucocorticoids affect the expressing of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus[J].J.Neurosci,1995,15(3 Pt 1):1768-1777.
[5]Siuciak JA,Lewis DR,Weiegand SJ et al.Antideprssan-dike effect of brain derived neurotrophic factor[J].Parmacol Biochem Behav,1997,56(1):131-137.
[6]Ueyama T,Kawai Y,Nemoto K,et al.Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain[J].Neurosci Res,1997,28(2): 103-110.
[7]Nibuya M,Morinobu S,Duman RS.Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments[J].J Neurosci 1995,15(11):7539-7547.
[8]Russo-Neustadt A,Beard RC,Cotman CW.Exercise,antidepressant medications,and enhanced brain derived neurotrophic factor expression[J].Neuropsycho-pharmacology 1999,21(5):679-682.
[9]Russo-Neustadt A,Ha T,Ramirez R,Kesslak JP.Physical activity-antidepressant treatment combination:impact on brain-derived neurotrophic factor and behavior in an animal model.Behav Brain Res 2001,120(1):87-95.
[10]Altar CA.Neurotrophins and depression[J].Trends Pharmacol Sci.1999,20(2):59-61.
[11]Chen B,Dowlatshahi D,MacQueen GM,Wang JF,Young LT.Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication[J].Biol Psychiatry 2001,50(4):260-265.
[12]Poo MM.Neurotrophins as synaptic modulators[J].Nat Rev Neurosci 2001,2(1):24-32.
[13]Lin LF,Doherty DH,Lile JD,Bektesh S,Collins F.GDNF:a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons[J].Science 1993;260(5111):1130-1132.
[14]Hisaoka K,Nishida A,Koda T et al.Antidepressant drug treatments induce glial cell line-derived neurotrophic factor(GDNF) synthesis and release in rat C6glioblastoma cells[J].J Neurochem 2001,79(1):25-34.
[15]Chen AC,Eisch AJ,Sakai N,Takahashi M,Nestler EJ,Duman RS.Regulation of GFR alpha-1 and GFR alpha-2 rnRNAs in rat brain by electroconvulsive seizure[J].Synapse 2001,39(1):42-50.
[16]王雪琦,山振东,赵小林,等.抑郁症大鼠海马和顶叶皮质神经元NGF含量及其mRNA的表达[[J].第二军医大学学报,2002,23(6):590-592
[17]王雪琦,路长林,孙学军,等.侧脑室微量注射神经生长因子对实验性抑郁症 大鼠抑郁行为和海马神经元损伤的影响[J].中国行为医学科学,2002,11(6):481-484.
[18]李春元,李梓.抗抑郁新药的临床研究进展[J].国外医药-合成药、生化药、制剂分册,2001,22(3):276-279.
[19]Shaywitz A,Greenberg M.CREB:a stimulus-induced transcription factor activated by a diverse array of extracellular signals[J].Annu Rev Biochem 1999,68:821-861.
[20]Lambert HW,Weiss ER,Lauder JM.Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells[J].Dev Neurosci 2001,23(1):70-77.
[21]Bonni A,Brunet A,West AE,Datta SR,Takasu MA,Greenberg ME.Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms[J].Science 1999,286(5443):1358-1362.
[22]Riccio A,Ahn S,Davenport CM,Blendy JA,Ginty DD.Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons[J].Science 1999,286(5448):2358-2361.
[23]Yuan J,Yankner BA.Apoptosis in the nervous system[J].Nature 2000,407(6805):802-809.
[24]Poo MM.Neurotrophins as synaptic modulators[J].Nat Rev Neurosci 2001,2(1):24-32.
[25]Kohara K,Kitamura A,Morishima M,Tsumoto T.Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons[J].Science 2001,291(5512):2419-2423.
[26]Shaywitz A,Greenberg M.CREB:a stimulus-induced transcription factor activated by a diverse array of extracellular signals[J].Annu Rev Biochem 1999,68:821-861.
[27]Drevets WC.Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression[J].Prog Brain Res 2000,126:413-431.
[28]Yu-Yin Huang,Chi-Hsien Peng,Yi-Ping Yang,et al.Desipramine Activated Bcl-2 Expression and Inhibited Lipopolysaccharide-Induced Apoptosis in Hippocampus -Derived Adult Neural Stem Cells[J].J Pharmacol Sci 2007,104(1):61-72
[29]Chi-Hsien Peng,Shih-Hwa Chiou,Shih-Jen Chen,et al.Neuroprotection by Imipramine against lipopo|ysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway[J].Eur Neuropsychopharmacol 2008,18(2):128-140
[30]Shih-Hwa Chiou,Hung-Hai Ku,Tung-Hu Tsai,et al.Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway[J].Br J Pharmacol 2006,148(5):587-598
[31]Wachtel H.The second-messenger dysbalance hypothesis of affective disorders [J].Pharmacopsychiatry,1990,23(1):27-32
[32]金光亮,周东丰,郭霞珍,等.慢性利血平抑郁模型大鼠脑内游离钙离子、钙调素和环核苷酸含量的变化[J].中华精神科杂志,1997,30(2):67-69
[33]Hsiung SC,Adlersberg M,Arango V,et al.Attenuated 5-HT1A receptor signaling in brains of suicide victims:involvement of adenylyl cyclase,phosphatidylinositol 3-kinase,Akt and mitogen-activated protein kinase[J].J Neurochem,2003,87(1):82-194
[34]Wachtel H.Potential antidepressant activity of rolipram and other seletive cyclic adenosine 3' 5'-monophosphate phosphodiesterase inhibitors[J].Neuro-pharmacology,1983,22(3):267-272
[35]刘艳梅,祁红,陈红专.抗抑郁药的信号转导机制[J].中国临床药理学与治疗学,2004,9(12):1321-1326.
[36]王珍琦,刘光伟,龚守良.抗抑郁药的神经保护作用及其机制[J].吉林大学学报:医学版,2004,30(5):827-830.
[37]Duman RS.Pathophysiology of depression:the concept of synaptic plasticity[J].Eur Psychiatry,2002,17(Suppl 3):306-310
[38]Dowlatshahi D,MacQueen GM,Wang JF,et al.Increased temporal cortex CREB concentrations and antidepressant in major depression[J].Lancet,1998,352(9142): 1754-1755
[39] Koch JM, Kell S , Hinze-Selch D, Al denhoff JB.Changes in CREB- phosphorylation during recovery from major depression[J].J Psychiatr Res, 2002,36(6):369-375
[40] Yamada S, Yamamoto M, Ozawa H, Riederer P, Saito T.Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder[J].J Neural Transm, 2003,110(6):671-680
[41] Nibuya M, Nestler EJ, Duman RS.Chronic, antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus[J]. JNeurosci ,1996,16(7):2365-2372
[42] Thome "J,Sakai N,Shin K,et al.cAMP response element-mediated gene transcription is upregulated by chronic antidepressant[J].J Neurosci, 2000,20(11):4030-4036
[43] Downward J.Signal transduction. Regulating S6 kinase[J].Nature, 1994,371(6496): 378-379.
[44] Siren AL Ehrenreich H.Erythropoietin a novel concept for neuroprotection [J].Eur Arch Psychiatry Clin Neurosci ,2001,251(4): 179-184
[45] Dudek H,Datta S R,Franke T F, et al.Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt[J].Science,1997,275(5330):661-665
[46] Widmann C ,Gibson S,Johnson G L.Caspase-dependent Cleavage of Signaling Proteins during Apoptosis[J].J Biol Chem, 1998,273(12):7141-7147
[47] Eves EM , Xiong W, Bellacosa A, et al.Akt, a Target of Phosphatidylinositol 3-Kinase, Inhibits Apoptosis in a Differentiating Neuronal Cell Line[J]. Mol Cell Biol, 1998,18(4):2143-2152
[48] Burgering BMT, Coffer P J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction[J] .Nature 1995, 376(6541):599-602
[49] Philpott KL,McCarthy M J, Klippel A, et al.Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons[J].J. Cell Biol,1997,139(3):809-815
[50] Yamashita K, Kajstura J, Discher D J, et al.Reperfusion-Activated Akt Kinase Prevents Apoptosis in Transgenic Mouse Hearts Overexpressing Insulin-Like Growth Factor-l[J].Circ Res,2001,88(6):609-614
[51] Datta SR,Brunet A,Greenberg M E.Cellular survival: a play in three Akts[J].Genes Dev,1999,13(22):2905-2927
[52] Yano S, Tokumitsu H, Soderling T R.Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway[J]. Nature, 1998,396 (6711):584-587
[53] Stephens L,Anderson K,Stokoe D,et al.Protein kinaseB Kinase that mediate phosphatidylinosiol 3,4,5-trisphosphate-activation of protein kinaseB [J].Science, 1998,279(5351):710-714.
[54] Pap M,and Coopes GM.Role of glycogen synthase kinase-3 in the phosphadylinositol3-kinase/Akt cell survival pathway[J].J Biol Chem,1998, 273(32):19929-19932
[55] Kennedy SG,Kandel ES,Cross TK,et al.Akt/protein kinase B inhibits cell death by preventing the release cytochrome C from mitochondria[J].Mol Cell Biol, 1999,19(8):5800-5810.
[56] Brunet A,Bonni A,Zigmond M J,et al.Akt promotes cell survival by phosphorylat- ing and inhibiting a Forkead transcription factor[J].Cell,1999,96(6):857-868.
[57] Rabincvitch A,Suarez-pinzon W,Strynadka K,et al.Transfection of human pancreatic islets with an anti-apoptotic gene(bcl-2) protects beta-cells from cytokine induced destruction[J].Diabetes,1999,48(6):1123-1129.
[58] Yano S,ToKumitsu H,Soderling TR.Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway[J] .Nature, 1998, 396 (6711):584-587.
[59] Schaeffer HJ,Weber MJ.Mitogen-activated protein kinases: specific messages from ubiquitous messengers[J].Mol.Cell. Biol. 1999,19(4):2435-2444
[60] Houslay MD, Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling[J].Mol.Pharmacol. 2000, 58(4):659-668
[61] Adams JP, Sweatt JD. Molecular psychology: roles for the ERK MAP kinase cascade in memory[J].Annu.Rev.Pharmacol.Toxicol.2002,42:135-163
[62] Adams JP, Roberson ED, English JD, Selcher JC, Sweatt JD.MAPK regulation of gene expression in the central nervous system[J].Acta Neurobiol Exp, 2000, 60(3):377-394
[63] Anderson NG,Maller JL,Tonks NK, Sturgill TW. Requirement for intergration of signals from two distinct phosphorylation pathways for activation of MAP kinase[J].Nature,1990,343(6254):651-653
[64] Crews CM, Alessandrini A, Erikson RL. The primary structure of MEK,a protein kinase that phosphorylate the ERK gene product[J]. Science, 1992,258 (5081):478-480
[65] Crews CM,Erikson RL Purification of a murine protein-tyrosine/threoninc kinase that phosphorylates and activates the Erk-1 gene product:relationship to the fission yeast byrl gene product[J].Proc.Natl. Acad.Sci.USA.1992,89(17):8205-8209
[66] Zheng CF, Guan KL.Properties of MEKs, the kinase that phosphorylate and activate the extracellular signal-regulated kinase[J]. J.Biol. Chem.1993,268(32):23933-23939
[67] Cantley LC, Auger KR, Carpenter C,et al. Oncogenes and signal transduction[J]. Cell.1991,64(2):281-302
[68] Gause KG, Homma MK, Licciardi KA,et al.Effects of phorbol ester on mitogen- activated protein kinase kinase activity in wild-type and phorbol ester-resistant EL4 thymoma cells[J]. J. Biol.Chem.1993,268(22):16124-16129
[69] Lev S, Moreno H, Martinez R,et al. Protein tyrosine kinase PYK2 involved in Ca(2+)- induced regulation of ion channel and MAP kinase functions [J] .Nature, 1995,376(6543):737-745
[70] Delia Rocca GJ ,Van Biesen T, Daaka Y ,et al.Ras-dependent mitogen-activated protein kinase activation by G protein- coupled receptors-convergence of kinase of Gi- and Gq-mediated pathways on calcium/calmodulin,Pyk2, and Src kinase[J].J.Biol.Chem. 1997,272(31): 19125-19132
[71] Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades[J].J.Biol.Chem. 1998,273(4): 1839-1842
[72] Roberson Ed, English JD, Adams JP,et al. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus [J]. J. Neurosci. 1999,19(11):4337-4348
[73] Sun H, Charles CH, Lau LE, Tonks NK.MKP-l(3CH134),an immediate early gene product,is a dual specificiy phosphatase that dephosphorylaaes MAP kinase in vivo[J]. Cell 1993,75(3):487-493
[74] Ward Y, gupta S, Jensen P,et al. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1[J]. Nature 1994,367(6464):651-654
[75] Chu Y, Solski PA, Khosravi-Far R,et al.The mitogen- activated protein kinase phosphatases PAC1,MKP-1 and MPK-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation[J].J.Biol.Chem.1996,271(11):6497-6501
[76] Muda M,Theodosiou A,Rodrigues N,et al.The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases[J].J Biol.Chem.l996,271(44):27205-27208
[77] Boulton T G,Nye S H, Robbins D J,et al. ERKs: a family of protein-serine/ threonine kinase that are activated and tyrosine phosphorylated in response to insulin and NGF[J]. Cell 1991,65(4):663-675
[78] Fiore RS, Bayer VE, Pelech SL, Cooper JA, Baraban JM. P42 mitogen-activated protein kinase in brain:prominent localization in neuronal cell bodies and dendrites[J].Neuroscience 1993,55(2):463-472
[79] Flood DG, Finn JP, Walton KM,et al.Immunolocalization of the mitogen- activated protein kinases P42 MAPK and JNK 1,and their regulatory kinases MEK1 and MEK 4,in adult rat central nervous system[J].J.Comp.Neurol. 1998,398(3):373-392
[80] Ortiz J, Harris HW,Guitart X,et al. Extracellular signal-regulated protein kinases (ERKs) and ERX kinase(MEK) in brain:regional distribution and regulation by chronic morphine[J].J.Neurosci. 1995,15(2): 1285-1297
[81] Brott BK, Alessandrini A, Largaespada DA,et al. MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues[J].Cell Growrth Differ,1993,4(11):921-929
[82] Dwivedi Y, Rizavi HS, Roberts RC,et al.Reduced activation and expression of ERK1/2 kinase in the post-mortem brain of depressed suicide subjects[J]. J Neurochem, 2001,77(3):916-928